{"meta":{"query_hash":"236721995b72","filters":{"venue":"OncoTargets and Therapy"},"cohort_total":79,"direct_labels_cover":0,"predictions_cover":79,"exported":79,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/236721995b72","api":"https://metacan.xera.ac/api/v1/cohort?venue=OncoTargets+and+Therapy"},"results":[{"id":"W1702959498","doi":"10.2147/ott.s85130","title":"CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies","year":2015,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Government of Jiangsu Province; Natural Science Foundation of Jiangsu Province; National Natural Science Foundation of China","keywords":"Medicine; Breast cancer; Androgen receptor; Odds ratio; Meta-analysis; Oncology; Internal medicine; Allele; Confidence interval; Subgroup analysis; Publication bias; Case-control study; Population; Cancer; Gynecology; Bioinformatics; Genetics; Prostate cancer; Gene; Biology","score_opus":0.08916752688260887,"score_gpt":0.3731327522712774,"score_spread":0.28396522538866853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1702959498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040219836,0.9568466,0.0010385731,0.0002729943,0.00017801645,0.00015899491,0.00078081863,0.00004726643,0.0004568321],"genre_scores_gemma":[0.59240115,0.40078235,0.0027998528,0.0007130829,0.00034512012,0.00062320346,0.0016120486,0.00005921259,0.00066387065],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99482995,0.002275497,0.0013175841,0.00077512267,0.0005557379,0.0002461828],"domain_scores_gemma":[0.99131256,0.006305187,0.0013159089,0.00038782178,0.0005242067,0.00015428766],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0068783876,0.0022505492,0.010178268,0.0032851417,0.0006511912,0.0023476856,0.0013366377,0.0014955229,0.0025088943],"category_scores_gemma":[0.012719463,0.0009868705,0.032447558,0.0069745206,0.00045984038,0.00094313297,0.0009813542,0.0015500055,0.0002587822],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048443275,0.000041491956,0.03224783,0.055415854,0.89681554,0.00033701485,0.000066039924,0.0007667946,0.00046200107,0.000086502645,0.0005418908,0.008374771],"study_design_scores_gemma":[0.0004175828,0.00019398765,0.014247838,0.0026568605,0.98101854,0.0001417622,0.000029928615,0.00027352705,0.00014101775,0.00013179773,0.0007321883,0.000014891354],"about_ca_topic_score_codex":0.0040324433,"about_ca_topic_score_gemma":0.007442062,"teacher_disagreement_score":0.98982173,"about_ca_system_score_codex":0.0012479555,"about_ca_system_score_gemma":0.0012493933,"threshold_uncertainty_score":0.036376834},"labels":[],"label_agreement":null},{"id":"W1740131825","doi":"10.2147/ott.s84034","title":"Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Meta-analysis; Medicine; Odds ratio; Subgroup analysis; Confidence interval; Prostate cancer; Internal medicine; Oncology; Cancer","score_opus":0.16089995007452496,"score_gpt":0.37259697487077964,"score_spread":0.21169702479625468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740131825","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053469952,0.94002855,0.0025795544,0.00048935914,0.0002996589,0.00032757563,0.0021116526,0.00010758121,0.00058618124],"genre_scores_gemma":[0.7171795,0.26962373,0.0064321426,0.0009729159,0.0004626126,0.0012013547,0.0031519274,0.0001234638,0.0008523528],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99132115,0.0036653422,0.002306941,0.0014537218,0.0008596748,0.00039315678],"domain_scores_gemma":[0.9873581,0.009234989,0.0016013231,0.00074294687,0.00084660883,0.00021598337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013031114,0.003413162,0.01263855,0.0062425546,0.0010093546,0.0027684844,0.0020776195,0.0020969084,0.0030494481],"category_scores_gemma":[0.019540582,0.0017531326,0.044362184,0.0084918095,0.0006869694,0.0012953868,0.0017618614,0.0018972579,0.00036144408],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004089874,0.000034506895,0.03013436,0.041793857,0.91552556,0.0003009999,0.000083751176,0.00066460425,0.00068714126,0.000067313355,0.0004604585,0.0061576064],"study_design_scores_gemma":[0.00027879895,0.00013789629,0.009266434,0.0018961148,0.98717207,0.00012725852,0.000030687646,0.00019850572,0.00014852922,0.000108169894,0.0006203032,0.000015392798],"about_ca_topic_score_codex":0.005318906,"about_ca_topic_score_gemma":0.009668167,"teacher_disagreement_score":0.013031114,"about_ca_system_score_codex":0.0015099583,"about_ca_system_score_gemma":0.0020406612,"threshold_uncertainty_score":0.0689159},"labels":[],"label_agreement":null},{"id":"W1781552324","doi":"10.2147/ott.s90875","title":"Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lung cancer; Hazard ratio; Internal medicine; Confidence interval; Neutrophil to lymphocyte ratio; Meta-analysis; Oncology; Cochrane Library; Lymphocyte; Gastroenterology","score_opus":0.07185449878803782,"score_gpt":0.3266945549584599,"score_spread":0.25484005617042205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1781552324","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03499644,0.9612515,0.0014906813,0.00036684365,0.00024130229,0.00015042214,0.0010007393,0.000059998132,0.00044200735],"genre_scores_gemma":[0.7274467,0.2642662,0.003643866,0.0010845053,0.00045435395,0.0007577962,0.0015676826,0.00007817934,0.0007007594],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944893,0.0026893993,0.0012258029,0.0008534154,0.00047413213,0.00026795492],"domain_scores_gemma":[0.9901985,0.007214702,0.0013731536,0.00049926934,0.00052732544,0.00018711122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011646159,0.002874449,0.011952209,0.0043279435,0.00072324876,0.0027456447,0.0018620187,0.002315156,0.0024194517],"category_scores_gemma":[0.016014045,0.0015845869,0.055652447,0.0051081404,0.000608422,0.0013841011,0.0013482973,0.0019417467,0.00029185048],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045412234,0.000032944987,0.019889304,0.04521622,0.9232059,0.00015733881,0.000047839225,0.0010697758,0.00038050002,0.00007140556,0.00036950034,0.005017992],"study_design_scores_gemma":[0.00037490277,0.00018246725,0.0060403417,0.0016031917,0.9906714,0.00007009238,0.000018414923,0.00028667224,0.0001076833,0.00011478547,0.000515435,0.000014571404],"about_ca_topic_score_codex":0.0044229953,"about_ca_topic_score_gemma":0.008593574,"teacher_disagreement_score":0.011952209,"about_ca_system_score_codex":0.0012915018,"about_ca_system_score_gemma":0.0013335027,"threshold_uncertainty_score":0.061591566},"labels":[],"label_agreement":null},{"id":"W1966461118","doi":"10.2147/ott.s72974","title":"Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Lymph node; Mediastinal lymph node; Radiology; Endobronchial ultrasound; Lung cancer; Lymph; Mediastinal lymphadenopathy; Pathology; Biopsy; Cancer; Metastasis; Internal medicine","score_opus":0.06298299379743237,"score_gpt":0.36544294807560934,"score_spread":0.30245995427817696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966461118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75405574,0.019370474,0.21804652,0.0004717826,0.00017049751,0.0007017925,0.0006296337,0.00091087236,0.0056426087],"genre_scores_gemma":[0.72415775,0.0031986425,0.26967755,0.00021012388,0.00016668154,0.00033759788,0.0009508592,0.00014850957,0.0011522896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973552,0.0008009087,0.00024635973,0.0005718375,0.00087330287,0.00015239991],"domain_scores_gemma":[0.9957223,0.0017947364,0.00047045818,0.0007411203,0.0010976235,0.00017376718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033232078,0.0006467498,0.000773612,0.0020892485,0.00032853853,0.00090386,0.00062138244,0.0006202015,0.0018973561],"category_scores_gemma":[0.0042402684,0.00039287534,0.0003919949,0.00066878233,0.00065618864,0.00086843385,0.00077642576,0.00054607424,0.0020347608],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011569259,0.00023085551,0.097442515,0.00047243215,0.000094415496,0.0009429712,0.0003432235,0.00059786584,0.77876353,0.00025340234,0.0004935271,0.11920834],"study_design_scores_gemma":[0.00013803082,0.001926179,0.21656403,0.00042201753,0.00061383867,0.019342657,0.00071964867,0.015738139,0.7250306,0.0012024845,0.018229028,0.00007334125],"about_ca_topic_score_codex":0.000347953,"about_ca_topic_score_gemma":0.000760259,"teacher_disagreement_score":0.0033232078,"about_ca_system_score_codex":0.0002735586,"about_ca_system_score_gemma":0.00044102772,"threshold_uncertainty_score":0.017575026},"labels":[],"label_agreement":null},{"id":"W1987367854","doi":"10.2147/ott.s30373","title":"Profile of erlotinib and its potential in the treatment of advanced ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Erlotinib; Ovarian carcinoma; Medicine; Oncology; Carcinoma; Internal medicine; Ovarian cancer; Cancer research; Cancer; Epidermal growth factor receptor","score_opus":0.015431443605721327,"score_gpt":0.2651156672300822,"score_spread":0.24968422362436085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987367854","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8843221,0.10031682,0.0007760936,0.0017782385,0.00017277268,0.00021866315,0.0008790813,0.000058839923,0.011477356],"genre_scores_gemma":[0.9803241,0.015976733,0.00052751903,0.00030580437,0.00009235553,0.0000310723,0.00062457897,0.000010691969,0.0021071855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985504,0.000046132907,0.00001778514,0.000010480541,0.000044718705,0.000025896754],"domain_scores_gemma":[0.9997197,0.00006676661,0.000054668315,0.000012187034,0.00006186986,0.00008481273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051300967,0.0001476218,0.000611797,0.00038756477,0.00015986986,0.0004324882,0.0001434682,0.0002629293,0.0014878135],"category_scores_gemma":[0.0007354544,0.000070184025,0.0003015504,0.0004929916,0.00009945518,0.00024827578,0.0001560792,0.00055945734,0.0002928455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027444223,0.0019100414,0.024743687,0.0013235311,0.00065014407,0.0019594885,0.00022661191,0.0040019453,0.14963163,0.0009982456,0.004648881,0.78246164],"study_design_scores_gemma":[0.009899844,0.15773821,0.41079557,0.0006719118,0.0027315938,0.018451313,0.00047118356,0.011229153,0.16076516,0.001369415,0.22572504,0.00015167888],"about_ca_topic_score_codex":0.0007673451,"about_ca_topic_score_gemma":0.002224172,"teacher_disagreement_score":0.0014878135,"about_ca_system_score_codex":0.0003307185,"about_ca_system_score_gemma":0.00031635637,"threshold_uncertainty_score":0.004977286},"labels":[],"label_agreement":null},{"id":"W2016406604","doi":"10.2147/ott.s53348","title":"Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Extramedullary hematopoiesis; Pharmacology; Intensive care medicine; Internal medicine; Oncology; Bone marrow; Haematopoiesis","score_opus":0.00958283741905231,"score_gpt":0.25374510316316334,"score_spread":0.24416226574411104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016406604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965095,0.002700856,0.00008173596,0.0001126778,0.000021969669,0.00010281929,0.000058109687,0.000009200445,0.00040321905],"genre_scores_gemma":[0.99903524,0.00034667202,0.00017660178,0.00012400403,0.000050159284,0.00008686938,0.00010286012,0.000001142335,0.00007648822],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99937505,0.000323153,0.000086697946,0.00008761123,0.000070808455,0.000056663786],"domain_scores_gemma":[0.9991455,0.00028518646,0.00033905348,0.00003738318,0.00003212882,0.0001606613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012998155,0.00033396867,0.0009458186,0.00021304512,0.00018178363,0.0004494193,0.00033215084,0.0005351015,0.00094417855],"category_scores_gemma":[0.0020607638,0.00014764504,0.0007026507,0.00023905194,0.00029272772,0.00041452766,0.0001798228,0.0007947876,0.00009457446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69114876,0.0136321625,0.07633633,0.0008319676,0.0024374009,0.00031374977,0.00022550367,0.0025588602,0.011959523,0.00022061141,0.0011152516,0.19921984],"study_design_scores_gemma":[0.2700197,0.39594284,0.31890434,0.00025748793,0.0022857548,0.00084840076,0.00014749268,0.0036078482,0.0046339496,0.0003740185,0.0029213985,0.000056691846],"about_ca_topic_score_codex":0.00023034941,"about_ca_topic_score_gemma":0.0005704851,"teacher_disagreement_score":0.0012998155,"about_ca_system_score_codex":0.0004323606,"about_ca_system_score_gemma":0.00035551962,"threshold_uncertainty_score":0.006874144},"labels":[],"label_agreement":null},{"id":"W2026240866","doi":"10.2147/ott.s55344","title":"Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Sialidase; Pancreatic cancer; Cancer; Medicine; Cancer research; Oncology; Internal medicine; Virology; Neuraminidase; Virus","score_opus":0.012952168741766575,"score_gpt":0.2825901730194355,"score_spread":0.26963800427766893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026240866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728525,0.0012431451,0.00071677606,0.00003115479,0.000013610402,0.000024253077,0.00006421681,0.00003131588,0.0005904437],"genre_scores_gemma":[0.9978077,0.0006635076,0.0009403421,0.000012927022,0.0000059255153,0.000021900094,0.00012534756,0.0000047682465,0.00041760408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992716,0.000013820386,0.000005944176,0.000013330591,0.00001807855,0.000021546628],"domain_scores_gemma":[0.9999645,0.0000069453054,0.000010522041,0.0000063692873,0.0000031919913,0.000008512975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012838494,0.0002676601,0.00025260038,0.00017207042,0.000095852374,0.00026320093,0.00021472634,0.0002002014,0.00069629337],"category_scores_gemma":[0.000081464386,0.00009279566,0.00022248614,0.00012778598,0.00016604956,0.00014309386,0.0001349077,0.00040906548,0.00017080404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038157936,0.00015696678,0.00042964602,0.000042113403,0.000008787274,0.00007831804,0.000012992721,0.00015028066,0.9926764,0.00007392028,0.000052752825,0.0059362976],"study_design_scores_gemma":[0.000083790124,0.0019067181,0.003227892,0.0000057726315,0.000029934898,0.000507013,0.000013143016,0.00092644716,0.99173766,0.000021736976,0.0015370059,0.0000029149728],"about_ca_topic_score_codex":0.00027423678,"about_ca_topic_score_gemma":0.00038940113,"teacher_disagreement_score":0.00069629337,"about_ca_system_score_codex":0.00020513556,"about_ca_system_score_gemma":0.00018966514,"threshold_uncertainty_score":0.0023293495},"labels":[],"label_agreement":null},{"id":"W2028113228","doi":"10.2147/ott.s57338","title":"Quality of life assessment in advanced cancer patients treated at home, an inpatient unit, and a day care center","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer survivorship and care","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Palliative care; Cancer; Performance status; Physical therapy; Activities of daily living; Internal medicine; Nursing","score_opus":0.01985701977311151,"score_gpt":0.32887012930092835,"score_spread":0.30901310952781685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028113228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890304,0.000529809,0.00006101519,0.00004727018,0.000008653308,0.00001747936,0.00010768862,0.000002952375,0.00032204317],"genre_scores_gemma":[0.99937207,0.00012810632,0.0001555591,0.000040879262,0.00000959649,0.000021237654,0.00020226948,7.459089e-7,0.00006942459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995035,0.00023922478,0.000045294757,0.00005524247,0.00009278463,0.00006397266],"domain_scores_gemma":[0.9986541,0.00018708804,0.0005032509,0.0000313963,0.00020196925,0.00042212478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006592413,0.00022401445,0.00047046418,0.0005202187,0.00044240084,0.00050544937,0.00024121025,0.00033462935,0.0013235909],"category_scores_gemma":[0.001901785,0.000112380054,0.00053803436,0.0005675412,0.00024703494,0.00034197167,0.00045956584,0.00046553664,0.0001276699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013547967,0.00057300576,0.9776409,0.000106154694,0.00029205004,0.00013799281,0.00033847554,0.00031437183,0.00043538655,0.000020962667,0.0005998161,0.018186033],"study_design_scores_gemma":[0.00017506702,0.0023579418,0.99530315,0.000026252754,0.000074224816,0.0004442697,0.0003803588,0.0006109446,0.00014899376,0.000026099528,0.00044091247,0.000011777742],"about_ca_topic_score_codex":0.0014402356,"about_ca_topic_score_gemma":0.0017420938,"teacher_disagreement_score":0.0014402356,"about_ca_system_score_codex":0.000619515,"about_ca_system_score_gemma":0.00031152568,"threshold_uncertainty_score":0.0044949055},"labels":[],"label_agreement":null},{"id":"W2054208824","doi":"10.2147/ott.s60358","title":"Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Radiosurgery; Temozolomide; Common Terminology Criteria for Adverse Events; Radiation therapy; Tolerability; Toxicity; Dose fractionation; Progression-free survival; Oncology; Nuclear medicine; Chemotherapy; Internal medicine; Radiology; Adverse effect","score_opus":0.010109574582131657,"score_gpt":0.2715641339687017,"score_spread":0.2614545593865701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054208824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992642,0.00024255418,0.00011041231,0.000015764821,0.0000053156496,0.00005336991,0.00017249111,0.0000046509435,0.00013116287],"genre_scores_gemma":[0.9989042,0.00020249472,0.0001472724,0.000044774068,0.000015400161,0.000065408596,0.00045610245,0.000007123478,0.00015719087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921286,0.00017241613,0.00006162961,0.00027510955,0.00015418816,0.000123929],"domain_scores_gemma":[0.9989166,0.00010706062,0.00039428676,0.00018215585,0.0001391856,0.00026075135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011207969,0.00064872217,0.00089598825,0.0005830909,0.0007447472,0.00078427163,0.00038601243,0.00048984215,0.0011891746],"category_scores_gemma":[0.001210984,0.0004879673,0.0012871154,0.00076533016,0.0003621303,0.0005212531,0.00048930786,0.000811572,0.00043266383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041129314,0.0010927428,0.98394245,0.00004181934,0.0007638657,0.00093950634,0.00030945486,0.00014903872,0.0023073424,0.000034594606,0.00040800855,0.0058984538],"study_design_scores_gemma":[0.00069794897,0.008817153,0.9844589,0.000015883237,0.0007125831,0.0025020281,0.00046631615,0.00051757373,0.00049243035,0.000047532725,0.0012306884,0.000040956864],"about_ca_topic_score_codex":0.0037657714,"about_ca_topic_score_gemma":0.0039287996,"teacher_disagreement_score":0.0037657714,"about_ca_system_score_codex":0.0006285761,"about_ca_system_score_gemma":0.0008915863,"threshold_uncertainty_score":0.0074877143},"labels":[],"label_agreement":null},{"id":"W2057735943","doi":"10.2147/ott.s63302","title":"Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Oncology; Metastatic breast cancer; Progression-free survival; Breast cancer; Confidence interval; Population; Surrogate endpoint; Cancer; Overall survival","score_opus":0.02274941579887847,"score_gpt":0.35614130633805935,"score_spread":0.3333918905391809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057735943","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014453306,0.98031473,0.0021025767,0.0007056309,0.00020675661,0.00034346525,0.0009983486,0.000012703397,0.00086246],"genre_scores_gemma":[0.6591575,0.32504615,0.0070760176,0.0017765844,0.00088868116,0.0033757517,0.0022001404,0.000036909005,0.00044216338],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9424441,0.043101467,0.007484692,0.0021768198,0.0044312696,0.0003616095],"domain_scores_gemma":[0.8172206,0.15229273,0.023577573,0.002487948,0.0039549344,0.0004661743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060500953,0.00088782865,0.0044003595,0.006374618,0.00028969895,0.0021877694,0.0012873712,0.001317892,0.0018165117],"category_scores_gemma":[0.11285554,0.00039248582,0.009669559,0.0064068893,0.0011041136,0.001994779,0.0011263824,0.00160357,0.00018503546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013405652,0.00013042732,0.100098796,0.4921448,0.1514561,0.00025674643,0.00060001574,0.0056712343,0.0007505817,0.006989026,0.0043616206,0.22413501],"study_design_scores_gemma":[0.0074022375,0.009826687,0.24941365,0.25353333,0.37980163,0.0025283042,0.00087133376,0.009372238,0.0025144813,0.026037687,0.05832799,0.00037041676],"about_ca_topic_score_codex":0.0010639618,"about_ca_topic_score_gemma":0.0018143315,"teacher_disagreement_score":0.060500953,"about_ca_system_score_codex":0.0016406165,"about_ca_system_score_gemma":0.0025472995,"threshold_uncertainty_score":0.31996346},"labels":[],"label_agreement":null},{"id":"W2072360921","doi":"10.2147/ott.s41397","title":"Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Neurofibromatosis; Neurofibroma; Schwannoma; Radiation therapy; Pathological; Malignant peripheral nerve sheath tumor; Nerve sheath neoplasm; Nerve sheath tumor; Surgery; Radiology; Pathology","score_opus":0.026105458024629942,"score_gpt":0.2581640071450141,"score_spread":0.23205854912038415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072360921","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030402595,0.9648726,0.0015851599,0.016518489,0.007392179,0.000028999084,0.00020479443,0.00009970855,0.006257772],"genre_scores_gemma":[0.013415301,0.95862556,0.0043735495,0.008506094,0.012412588,0.00003628171,0.0006779538,0.000029072684,0.0019237498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987925,0.0002948554,0.00038867688,0.00010895209,0.00034394296,0.00007106904],"domain_scores_gemma":[0.99191874,0.0035621927,0.0012205926,0.000146953,0.002839077,0.00031255785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023693487,0.0005557288,0.0007736794,0.0034811804,0.00032411065,0.0012642907,0.0011202316,0.001715351,0.0021171335],"category_scores_gemma":[0.0076666144,0.0003200916,0.0007523409,0.0020527598,0.0006120647,0.002425401,0.0006134061,0.0023479841,0.0010314991],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014487983,0.000078839235,0.004177604,0.009883791,0.00014426655,0.0014207523,0.00024372453,0.00050300243,0.0016458883,0.001440115,0.12685946,0.85345775],"study_design_scores_gemma":[0.000027708711,0.0001614284,0.0051538222,0.011364516,0.00040771277,0.008274775,0.0003035226,0.0002651644,0.00092843326,0.0012943827,0.97178155,0.000037008333],"about_ca_topic_score_codex":0.0020146114,"about_ca_topic_score_gemma":0.0040377015,"teacher_disagreement_score":0.0034811804,"about_ca_system_score_codex":0.00095039257,"about_ca_system_score_gemma":0.0014366495,"threshold_uncertainty_score":0.012530446},"labels":[],"label_agreement":null},{"id":"W2078214711","doi":"10.2147/ott.s38403","title":"β-blockers: a novel class of antitumor agents","year":2012,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"Fudan University; National Natural Science Foundation of China; National Science Foundation","keywords":"BETA (programming language); Class (philosophy); Pharmacology; Medicine; Chemistry; Computer science; Artificial intelligence; Programming language","score_opus":0.04348671431179846,"score_gpt":0.30943908477307996,"score_spread":0.2659523704612815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078214711","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23317572,0.67347264,0.01767764,0.007380126,0.0026898715,0.00030587232,0.0008604874,0.00071910274,0.06371851],"genre_scores_gemma":[0.58816266,0.34763518,0.019773474,0.0050299573,0.0031108826,0.00044245878,0.0009855625,0.000082321574,0.034777414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999442,0.00000958291,0.0000045191928,0.000013454504,0.0000139613485,0.000014325099],"domain_scores_gemma":[0.99994695,0.000007570569,0.000011989644,0.0000032256855,0.000007013909,0.000023181741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015265899,0.0004036262,0.00052468234,0.00046052996,0.00022340636,0.0005897642,0.00031374357,0.00042168525,0.0019518583],"category_scores_gemma":[0.000118239084,0.00010360436,0.00020444335,0.00025090532,0.00025000126,0.00039498208,0.0003221572,0.0014072298,0.0010449965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014204885,0.00090916763,0.00088278396,0.0011669185,0.00005478286,0.0014232269,0.00014183288,0.00057628215,0.2168766,0.009647464,0.012062486,0.754838],"study_design_scores_gemma":[0.002119393,0.009483612,0.008877982,0.00046930066,0.00020954006,0.013557067,0.0001232732,0.002444967,0.16312051,0.0060882536,0.7934033,0.00010283804],"about_ca_topic_score_codex":0.00011654933,"about_ca_topic_score_gemma":0.00031007823,"teacher_disagreement_score":0.0019518583,"about_ca_system_score_codex":0.00021550636,"about_ca_system_score_gemma":0.00022253726,"threshold_uncertainty_score":0.0065295696},"labels":[],"label_agreement":null},{"id":"W2088964260","doi":"10.2147/ott.s59227","title":"Cancer cell-oriented migration of mesenchymal stem cells engineered with an anticancer gene (PTEN): an imaging demonstration","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia; Natural Science Foundation of Guangxi Province","keywords":"PTEN; Tensin; Mesenchymal stem cell; Cancer research; Cell; Cell migration; Gene delivery; Transfection; Cancer cell; Stem cell; Biology; Cell culture; Cancer; Cell biology; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.015285918774809263,"score_gpt":0.28121630622995464,"score_spread":0.26593038745514536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088964260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830472,0.0005902584,0.014137589,0.00009818917,0.00002245932,0.000023797294,0.00009961841,0.00012782478,0.001852988],"genre_scores_gemma":[0.9799448,0.0007225132,0.017524535,0.000034787852,0.000008406659,0.000034486206,0.0001267787,0.000024400102,0.0015792265],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999497,0.0000055303904,0.0000034256877,0.000010477396,0.000018830253,0.000011970287],"domain_scores_gemma":[0.99992836,0.000021299162,0.000015797732,0.0000063286725,0.00001364538,0.000014583923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013877395,0.0002510783,0.00008155019,0.00025210113,0.00011563714,0.00012277885,0.00012710944,0.00022130074,0.0005826231],"category_scores_gemma":[0.000071371695,0.00008620584,0.0001763916,0.00012335398,0.00016375675,0.00013672923,0.000106695305,0.0002886634,0.00020497094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001745848,0.000013322103,0.00015133247,0.000014862646,0.0000011367695,0.000063998385,0.000020816244,0.00005029493,0.9983322,0.000118787764,0.000022928307,0.0011928028],"study_design_scores_gemma":[0.000004870716,0.000083133666,0.0013123259,0.000002073688,0.000005228861,0.00020009636,0.000014346774,0.0008444485,0.99691087,0.000019850824,0.0006006616,0.00000207164],"about_ca_topic_score_codex":0.0009130295,"about_ca_topic_score_gemma":0.00078524376,"teacher_disagreement_score":0.0009130295,"about_ca_system_score_codex":0.00016255108,"about_ca_system_score_gemma":0.00021282322,"threshold_uncertainty_score":0.0019491315},"labels":[],"label_agreement":null},{"id":"W2092597257","doi":"10.2147/ott.s71089","title":"Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Thymidine phosphorylase; Capecitabine; Breast cancer; Medicine; Oncology; Estrogen receptor; Internal medicine; Immunohistochemistry; Cancer; Progesterone receptor; Tumor progression; Stage (stratigraphy); Metastatic breast cancer; Clinical significance; Pathology; Biology; Colorectal cancer","score_opus":0.035540847519078336,"score_gpt":0.2834232823298414,"score_spread":0.24788243481076305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092597257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994735,0.00012233779,0.00010391123,0.000007786307,0.0000022733125,0.0000115630255,0.00012899948,0.0000026536636,0.00014707609],"genre_scores_gemma":[0.9995179,0.00006159877,0.00010283633,0.000013133006,0.000008420552,0.000013466787,0.00021796503,0.0000026875894,0.00006190411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939597,0.00015084642,0.00006397609,0.00021362735,0.0000889999,0.00008662521],"domain_scores_gemma":[0.99787784,0.00052513374,0.00069645984,0.00021383585,0.00026260604,0.00042403306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008426496,0.0003752391,0.00056968763,0.00091359246,0.00061666855,0.0006054545,0.00033164205,0.00038172232,0.0021962214],"category_scores_gemma":[0.0020326558,0.0003706874,0.0005021531,0.0012036717,0.00047017116,0.00045953604,0.00047029107,0.00039370355,0.0004327484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032954285,0.0000436417,0.99809545,0.000007433859,0.00004729087,0.00028709896,0.000053329404,0.000025856925,0.00037228363,0.0000069195635,0.00003641626,0.000694822],"study_design_scores_gemma":[0.000047085072,0.0010067462,0.99505496,0.000007835464,0.00010665508,0.0024444868,0.00034945886,0.00031310803,0.00031095656,0.000020601356,0.00032694614,0.000011121697],"about_ca_topic_score_codex":0.0024219642,"about_ca_topic_score_gemma":0.0021156098,"teacher_disagreement_score":0.0024219642,"about_ca_system_score_codex":0.000467792,"about_ca_system_score_gemma":0.00046588364,"threshold_uncertainty_score":0.007347107},"labels":[],"label_agreement":null},{"id":"W2093544818","doi":"10.2147/ott.s30238","title":"Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options","year":2013,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Ovarian cancer; Olaparib; Oncology; Internal medicine; Chemotherapy; Systemic therapy; Bevacizumab; Clinical trial; Cancer; Polymerase; Breast cancer; Poly ADP ribose polymerase","score_opus":0.027344287524817407,"score_gpt":0.30800633036633196,"score_spread":0.2806620428415145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093544818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005044338,0.9977325,0.00015842302,0.0009914881,0.00007342014,0.000007138565,0.000015397713,0.000005904075,0.00051120174],"genre_scores_gemma":[0.0057849777,0.9925292,0.00043552637,0.0007075324,0.0002841831,0.000016204167,0.000032623087,0.0000019627503,0.00020781367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997495,0.00009247051,0.000057493064,0.000028998684,0.000056872585,0.000014727623],"domain_scores_gemma":[0.99917233,0.00046562921,0.00022509992,0.000012315716,0.00008765245,0.00003694001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007512072,0.00035946083,0.0010084242,0.00095312844,0.00017291993,0.00063331914,0.00038167703,0.0005165868,0.0034938147],"category_scores_gemma":[0.0015443631,0.00013749853,0.00067161315,0.00090047676,0.00029098277,0.0010337131,0.00034158427,0.0005843925,0.00049093296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002596805,0.000051002968,0.0012052559,0.047422424,0.00027832008,0.00049476215,0.00007173103,0.00025980436,0.0012605515,0.00069035677,0.01167948,0.9363267],"study_design_scores_gemma":[0.00055877474,0.002187721,0.018953603,0.11216994,0.0048132567,0.020143392,0.0010545342,0.00088677974,0.0021622765,0.005041636,0.831955,0.00007318739],"about_ca_topic_score_codex":0.00039913357,"about_ca_topic_score_gemma":0.00192992,"teacher_disagreement_score":0.0034938147,"about_ca_system_score_codex":0.00038563157,"about_ca_system_score_gemma":0.0009793236,"threshold_uncertainty_score":0.011687994},"labels":[],"label_agreement":null},{"id":"W2106504686","doi":"10.2147/ott.s14503","title":"Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells","year":2010,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Hôpital Notre-Dame","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Université du Québec à Montréal","keywords":"Protein kinase B; Propranolol; Phosphorylation; Signal transduction; MAPK/ERK pathway; Kinase; Pharmacology; Cell biology; Chemistry; Cancer research; Biology; Endocrinology; Internal medicine; Medicine","score_opus":0.015973263898780725,"score_gpt":0.27814749082608886,"score_spread":0.26217422692730813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106504686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958801,0.0011496403,0.0013671643,0.00006779249,0.000027087955,0.000032320666,0.0003963812,0.000038290742,0.0010411709],"genre_scores_gemma":[0.99507034,0.0011027197,0.0014894478,0.00003154776,0.000011651608,0.00006921131,0.00045520478,0.000009870595,0.0017599645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998505,0.000018993585,0.000019539626,0.000023504665,0.000037075522,0.000050385934],"domain_scores_gemma":[0.9999262,0.000018965375,0.000017881737,0.000009311552,0.0000062496683,0.000021466782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014359754,0.000276941,0.0002474208,0.00016232557,0.000102144964,0.00021852963,0.00017431699,0.00016386624,0.0011196907],"category_scores_gemma":[0.00008283834,0.00011918531,0.00025190366,0.00015232134,0.00019899348,0.00014113425,0.000111304515,0.0007338784,0.0003033448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065305525,0.000035543904,0.00005767002,0.00001820681,0.0000026449918,0.000018209243,0.000010075364,0.000030350546,0.9992723,0.000030119181,0.000015273004,0.000444337],"study_design_scores_gemma":[0.000024804529,0.00052212697,0.0032395697,0.0000044254903,0.0000127720405,0.000101877944,0.0000313108,0.00053129287,0.9939884,0.000020595962,0.0015202393,0.0000025438233],"about_ca_topic_score_codex":0.0009793143,"about_ca_topic_score_gemma":0.0018359501,"teacher_disagreement_score":0.0011196907,"about_ca_system_score_codex":0.0002157358,"about_ca_system_score_gemma":0.00024095878,"threshold_uncertainty_score":0.0037457943},"labels":[],"label_agreement":null},{"id":"W2114890848","doi":"10.2147/ott.s62717","title":"Transcriptional targeting of sphingosine-1- phosphate receptor S1P2 by epigallocatechin- 3-gallate prevents sphingosine-1-phosphate- mediated signaling in macrophage-differentiated HL-60 promyelomonocytic leukemia cells","year":2014,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Université du Québec à Montréal","keywords":"Neuroinflammation; Cell biology; Kinase; Signal transduction; MAPK/ERK pathway; Sphingosine kinase; p38 mitogen-activated protein kinases; Sphingosine; Cancer research; Sphingosine-1-phosphate; Biology; Receptor; Inflammation; Immunology; Biochemistry","score_opus":0.006424711646603753,"score_gpt":0.21503700845133011,"score_spread":0.20861229680472637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114890848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940587,0.0012941657,0.0025765407,0.00015705095,0.0000525785,0.000052541553,0.00070430175,0.00012274785,0.0009812512],"genre_scores_gemma":[0.9935189,0.00073469785,0.0020275514,0.0000933344,0.000015769358,0.0000918611,0.0011723432,0.000026037587,0.0023194072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997892,0.000034064673,0.00002624428,0.00004092207,0.000045483695,0.0000641196],"domain_scores_gemma":[0.9998841,0.000020626923,0.00003353417,0.00001759673,0.000015129729,0.000029011386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023532599,0.00048993883,0.00034196483,0.00022526445,0.00014277124,0.00033089984,0.0002303413,0.00029238826,0.0009319884],"category_scores_gemma":[0.00011236817,0.00015087322,0.00045699414,0.00021686887,0.0003957002,0.00017478483,0.00019374391,0.00063077017,0.00048373564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019599013,0.000038458165,0.00006595936,0.0000309301,0.00000384009,0.000022397371,0.000015824737,0.000041444782,0.99918956,0.000041563126,0.000025479241,0.00032861385],"study_design_scores_gemma":[0.00003070111,0.00034851162,0.0015419112,0.0000041718336,0.000015404192,0.00005761363,0.000023978555,0.0006170822,0.9962998,0.000019578752,0.0010382774,0.0000031017373],"about_ca_topic_score_codex":0.00049572304,"about_ca_topic_score_gemma":0.0007292097,"teacher_disagreement_score":0.0009319884,"about_ca_system_score_codex":0.00032265022,"about_ca_system_score_gemma":0.0003027684,"threshold_uncertainty_score":0.0031177998},"labels":[],"label_agreement":null},{"id":"W2120430486","doi":"10.2147/ott.s87580","title":"Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis","year":2015,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Hepatectomy; Internal medicine; Splenectomy; Gastroenterology; Confidence interval; Perioperative; Cochrane Library; Meta-analysis; White blood cell; Surgery; Spleen","score_opus":0.1711694128655097,"score_gpt":0.3016819767570187,"score_spread":0.13051256389150898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120430486","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04378545,0.95307946,0.0010533547,0.0003032484,0.0004079124,0.00045397202,0.0004474851,0.00004196527,0.0004271631],"genre_scores_gemma":[0.7074126,0.28537112,0.0027027398,0.0011386466,0.00065939635,0.0013487074,0.0007993189,0.0000443797,0.00052310247],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99307245,0.0035126226,0.0016958134,0.0008373029,0.00057337503,0.00030843422],"domain_scores_gemma":[0.98603445,0.010191473,0.0021945408,0.00053051143,0.00071649475,0.0003324589],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010658081,0.0025917597,0.018199217,0.0039305617,0.0006438015,0.0029084838,0.0020291873,0.0025738068,0.0036553824],"category_scores_gemma":[0.017828338,0.0014207683,0.051247444,0.004377365,0.00069897634,0.001605378,0.0013177559,0.0022081533,0.0003064265],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010045081,0.00007357599,0.0065107923,0.07037823,0.90796375,0.00012392532,0.000049697195,0.00036017492,0.00021858155,0.000052134492,0.00014142676,0.0040826895],"study_design_scores_gemma":[0.0012503894,0.0004967235,0.0032206997,0.002468266,0.9918454,0.00005692821,0.000025088659,0.00015303919,0.000058979695,0.00007076092,0.00034224862,0.000011442691],"about_ca_topic_score_codex":0.0034615444,"about_ca_topic_score_gemma":0.006457017,"teacher_disagreement_score":0.9818008,"about_ca_system_score_codex":0.0017217564,"about_ca_system_score_gemma":0.0020025526,"threshold_uncertainty_score":0.056366026},"labels":[],"label_agreement":null},{"id":"W2320733543","doi":"10.2147/ott.s97436","title":"Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cervical cancer; Cisplatin; Chemoradiotherapy; Medicine; Radiation therapy; Oncology; Meta-analysis; Internal medicine; Radiology; Cancer; Chemotherapy","score_opus":0.056964517858168244,"score_gpt":0.3392702648888527,"score_spread":0.28230574703068445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320733543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025779853,0.9698164,0.0021212066,0.00024277902,0.0004137971,0.00062496157,0.0005207427,0.000058244907,0.00042199533],"genre_scores_gemma":[0.61321306,0.37560725,0.0052904724,0.00123742,0.00056144624,0.0021216217,0.0011642204,0.00006970396,0.00073477696],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98932284,0.0060853087,0.0021870509,0.0011511304,0.0009394321,0.0003141579],"domain_scores_gemma":[0.9871127,0.00914211,0.0020500785,0.00055061805,0.0008701162,0.0002743546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017532753,0.0035242625,0.019763153,0.0040723495,0.0005162897,0.00331582,0.0023593686,0.0027589144,0.003302587],"category_scores_gemma":[0.025119957,0.0015547008,0.06498766,0.004446243,0.00066721113,0.0017878907,0.0014531361,0.0023005588,0.00031939903],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008905049,0.000048161273,0.0019070366,0.05860559,0.925221,0.000062003994,0.000029873429,0.0007570126,0.00018909133,0.00005771102,0.00012994221,0.0040875617],"study_design_scores_gemma":[0.0013401655,0.00036524585,0.0014846048,0.0023231886,0.9937057,0.000032106724,0.000014638633,0.00026985604,0.000065175824,0.00007674156,0.00031140083,0.000011099745],"about_ca_topic_score_codex":0.0045614736,"about_ca_topic_score_gemma":0.007140507,"teacher_disagreement_score":0.019763153,"about_ca_system_score_codex":0.002376502,"about_ca_system_score_gemma":0.0020247253,"threshold_uncertainty_score":0.09272313},"labels":[],"label_agreement":null},{"id":"W2325418286","doi":"10.2147/ott.s104004","title":"Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: comments on a meta-analysis by Liang et al","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Medicine; Bone Sarcoma; Soft tissue; Osteosarcoma; Meta-analysis; Sarcoma; Subgroup analysis; Value (mathematics); Soft tissue sarcoma; Orthopedic surgery; Oncology; Internal medicine; Pathology; Surgery; Computer science","score_opus":0.0397497882919545,"score_gpt":0.3303150941496893,"score_spread":0.29056530585773477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325418286","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019049756,0.5858451,0.002249605,0.37234816,0.034990747,0.0001224176,0.0015389808,0.000094233306,0.00090579275],"genre_scores_gemma":[0.07517138,0.24510245,0.0051387046,0.5787716,0.09141021,0.0007782627,0.00097142294,0.000338093,0.0023179015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.92776847,0.042080093,0.015978726,0.0049327705,0.008376998,0.0008629549],"domain_scores_gemma":[0.56458634,0.39619625,0.010721247,0.0058244425,0.02135739,0.0013142893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12766495,0.0024218769,0.006439164,0.004517986,0.0012164209,0.0036233843,0.0062495987,0.009719444,0.0042767],"category_scores_gemma":[0.32253313,0.0014354802,0.0188133,0.0064833164,0.0023129387,0.004586565,0.0022173664,0.009671038,0.001486764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007709853,0.00006696085,0.016578294,0.1423936,0.13084444,0.0022406906,0.0011824919,0.0019363243,0.00130009,0.008207229,0.58252335,0.105016686],"study_design_scores_gemma":[0.008517675,0.0013728016,0.025519606,0.15409769,0.34593838,0.0035819835,0.0012506584,0.0042172866,0.0036675364,0.03675115,0.41409153,0.0009937688],"about_ca_topic_score_codex":0.011387769,"about_ca_topic_score_gemma":0.010680454,"teacher_disagreement_score":0.12766495,"about_ca_system_score_codex":0.0045263856,"about_ca_system_score_gemma":0.0060916375,"threshold_uncertainty_score":0.6751649},"labels":[],"label_agreement":null},{"id":"W2346886569","doi":"10.2147/ott.s102286","title":"Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"Specialized Research Fund for the Doctoral Program of Higher Education of China; Beijing Municipal Administration of Hospitals; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; National Natural Science Foundation of China","keywords":"Medicine; Hematopoietic stem cell transplantation; Total body irradiation; Hematology; Transplantation; Single Center; Leukemia; Internal medicine; Myeloid leukemia; Stem cell; Christian ministry; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.019295167692144927,"score_gpt":0.2682242362239413,"score_spread":0.2489290685317964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346886569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945551,0.002621797,0.0018706436,0.00007889893,0.00001952917,0.000053393218,0.00007097034,0.000024333367,0.00070513785],"genre_scores_gemma":[0.9931786,0.0038056555,0.0022356599,0.00011437957,0.00008092584,0.000035941048,0.00031807905,0.000026024798,0.00020471669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995857,0.0001044235,0.00008311382,0.00009607209,0.0000661966,0.0000644751],"domain_scores_gemma":[0.9995414,0.000082138824,0.00010598913,0.000058380225,0.000035415844,0.00017664627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004980901,0.00068357924,0.00057996926,0.0004333379,0.00068453106,0.00043876647,0.0003511891,0.00036088974,0.0009408246],"category_scores_gemma":[0.0009076409,0.00020994534,0.00047868816,0.00067873555,0.00033941487,0.0005524895,0.0006028153,0.0005222997,0.00035810703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021254935,0.004940219,0.58343124,0.0006203421,0.00059704616,0.044168357,0.0033423323,0.002193468,0.027463416,0.00046232718,0.0018559226,0.32879987],"study_design_scores_gemma":[0.0013700655,0.032408006,0.59643084,0.00035550963,0.001213106,0.30266047,0.0026290999,0.0041570603,0.036979675,0.0007360376,0.020853741,0.00020639485],"about_ca_topic_score_codex":0.0004938629,"about_ca_topic_score_gemma":0.0009972075,"teacher_disagreement_score":0.0009408246,"about_ca_system_score_codex":0.00034033912,"about_ca_system_score_gemma":0.00059616595,"threshold_uncertainty_score":0.0031473637},"labels":[],"label_agreement":null},{"id":"W2375133443","doi":"10.2147/ott.s102578","title":"Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"Pfizer","keywords":"Axitinib; Medicine; Internal medicine; Sunitinib; Renal cell carcinoma; Oncology; Regimen; Response Evaluation Criteria in Solid Tumors; Cancer; Progressive disease; Disease","score_opus":0.05487739526461042,"score_gpt":0.3388670856391863,"score_spread":0.2839896903745759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2375133443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984664,0.00051328546,0.00010024285,0.00003265321,0.000004405204,0.000105069936,0.00012552939,0.0000043214336,0.0006480874],"genre_scores_gemma":[0.99929786,0.00010657716,0.00015490022,0.000042789085,0.000008302656,0.000079207915,0.00018011595,0.0000013209524,0.00012887758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991146,0.0003706419,0.00010645908,0.00011593799,0.00020279404,0.00008949796],"domain_scores_gemma":[0.99786204,0.0006212624,0.0008085144,0.000056123416,0.00020670776,0.00044529213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026371903,0.00024118059,0.0008381563,0.00034267872,0.00028555442,0.00035233164,0.00022712671,0.00022599027,0.0008051647],"category_scores_gemma":[0.0020013885,0.000080061276,0.0005066661,0.00032574314,0.00030158777,0.00027575405,0.00021378745,0.0003682305,0.00012004864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046068262,0.0016975333,0.9018938,0.00032486644,0.000668424,0.00033913075,0.00036017885,0.0011868738,0.0059361802,0.000087659624,0.0006566145,0.040780447],"study_design_scores_gemma":[0.002893908,0.031147512,0.95989996,0.000027811098,0.0002402858,0.00072825275,0.000111668494,0.0015752154,0.0024050316,0.000060609553,0.00088868424,0.000021062244],"about_ca_topic_score_codex":0.0016667228,"about_ca_topic_score_gemma":0.004570355,"teacher_disagreement_score":0.0026371903,"about_ca_system_score_codex":0.0009763025,"about_ca_system_score_gemma":0.00084509404,"threshold_uncertainty_score":0.01394695},"labels":[],"label_agreement":null},{"id":"W2464322340","doi":"10.2147/ott.s104334","title":"Association between pesticide exposure and risk of kidney cancer: a meta-analysis","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Meta-analysis; Kidney cancer; Medicine; Environmental health; Cancer; Pesticide; Oncology; Toxicology; Internal medicine; Biology; Ecology","score_opus":0.017280140937013473,"score_gpt":0.27008138252475355,"score_spread":0.2528012415877401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464322340","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011175318,0.98520225,0.0016805129,0.00029510816,0.0002920405,0.00032773678,0.0006675642,0.000045662822,0.00031372005],"genre_scores_gemma":[0.30133888,0.68694127,0.0062074168,0.0012244876,0.0007179099,0.001380744,0.001358871,0.00007199775,0.000758413],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99177563,0.0041237506,0.0019180211,0.0010269291,0.0008124035,0.00034333812],"domain_scores_gemma":[0.9896946,0.007587024,0.0012216066,0.00048947707,0.0008488968,0.00015847203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01203328,0.0038785015,0.018725723,0.007889718,0.0008253008,0.0034184046,0.0020192235,0.0026012051,0.002827107],"category_scores_gemma":[0.024040984,0.0019765461,0.065794215,0.008073779,0.0004815781,0.0018462349,0.0015321166,0.0024960735,0.0003092451],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021271496,0.00003307674,0.005811783,0.07215201,0.9127124,0.000144013,0.000033912518,0.0006194787,0.00028248053,0.00007646037,0.00029972664,0.005707499],"study_design_scores_gemma":[0.00028631574,0.00014242885,0.0024313247,0.002712222,0.99337643,0.00007357686,0.000013142731,0.00016256007,0.00010276753,0.00009906686,0.00058787304,0.000012269431],"about_ca_topic_score_codex":0.006201436,"about_ca_topic_score_gemma":0.011738514,"teacher_disagreement_score":0.018725723,"about_ca_system_score_codex":0.002344573,"about_ca_system_score_gemma":0.002703861,"threshold_uncertainty_score":0.063638866},"labels":[],"label_agreement":null},{"id":"W2528485638","doi":"10.2147/ott.s110203","title":"Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Natural Science Foundation of Zhejiang Province","keywords":"Downregulation and upregulation; Cancer; Medicine; Internal medicine; Oncology; Cancer research; Biology; Gene","score_opus":0.0054475422700657455,"score_gpt":0.21508752687669713,"score_spread":0.20963998460663139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528485638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978764,0.0012795859,0.00028942325,0.00004039347,0.000006216655,0.0000048345873,0.00022210095,0.000011071948,0.00027007845],"genre_scores_gemma":[0.9988663,0.00031508104,0.0002641075,0.000021010099,0.0000125858,0.0000072571297,0.000294014,0.0000021822464,0.00021737823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999349,0.000012720081,0.0000058570795,0.000013969941,0.000017410894,0.00001511632],"domain_scores_gemma":[0.99985003,0.000023004857,0.00007275408,0.000006149498,0.0000201342,0.000027930253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013573638,0.00018835011,0.0002164978,0.0004069585,0.00015380286,0.00021607093,0.00008596605,0.00014934615,0.0009066685],"category_scores_gemma":[0.00028790097,0.0000626564,0.000113241615,0.00040285068,0.00016681271,0.00011544743,0.00017523939,0.0001723098,0.00014804301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015186366,0.000066242144,0.88060427,0.00014738528,0.000085492495,0.00039927455,0.00008979442,0.00016975804,0.10492927,0.00005561469,0.00027060157,0.011663679],"study_design_scores_gemma":[0.000009402674,0.00014619148,0.9911,0.0000069290118,0.00006662552,0.00066065567,0.00010645246,0.00035164758,0.0066412063,0.000067289744,0.0008392209,0.000004419373],"about_ca_topic_score_codex":0.00034015797,"about_ca_topic_score_gemma":0.0005651418,"teacher_disagreement_score":0.0009066685,"about_ca_system_score_codex":0.000116332594,"about_ca_system_score_gemma":0.00011027617,"threshold_uncertainty_score":0.0030331612},"labels":[],"label_agreement":null},{"id":"W2549312266","doi":"10.2147/ott.s109650","title":"Effect of smoking on the genetic makeup of toll-like receptors 2 and 6","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"TLR2; Single-nucleotide polymorphism; Genotype; SNP; Medicine; Population; Innate immune system; Cotinine; Immunology; Saliva; Receptor; Nicotine; Internal medicine; Biology; Gene; Genetics; Environmental health","score_opus":0.006602049319220464,"score_gpt":0.22510039657051953,"score_spread":0.21849834725129907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549312266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988574,0.00040839295,0.00010122384,0.000038472666,0.000017648741,0.0000044984913,0.0001069351,0.000004846512,0.00046066815],"genre_scores_gemma":[0.99916434,0.00011057355,0.00007991963,0.000023568258,0.00001013892,0.000005001279,0.00011255405,0.0000041878448,0.00048976095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964404,0.00012473438,0.000024153207,0.000093002156,0.000057489084,0.00005661583],"domain_scores_gemma":[0.9990295,0.00038544252,0.0001858975,0.00010910814,0.00009162103,0.00019840576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234912,0.0004014294,0.00024969893,0.00032774798,0.00023476509,0.00037433198,0.00021503224,0.000490253,0.0039482787],"category_scores_gemma":[0.0012491888,0.00019217526,0.00067555084,0.0002398867,0.00021946905,0.00014912289,0.00021346929,0.00048367685,0.00031176637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004865172,0.00026808764,0.970256,0.000031733784,0.0005622271,0.00032279707,0.00008808956,0.00005596457,0.01736683,0.000083023624,0.00013934729,0.005960669],"study_design_scores_gemma":[0.00003920792,0.000846161,0.99663025,0.000007685054,0.00034857634,0.00046188798,0.000039900213,0.00023138335,0.0010322344,0.00007782947,0.0002799082,0.000005000989],"about_ca_topic_score_codex":0.0013424314,"about_ca_topic_score_gemma":0.00076326646,"teacher_disagreement_score":0.0039482787,"about_ca_system_score_codex":0.00013004323,"about_ca_system_score_gemma":0.0001847472,"threshold_uncertainty_score":0.01320827},"labels":[],"label_agreement":null},{"id":"W2562421369","doi":"10.2147/ott.s106024","title":"Association between <em>TLR-9</em> polymorphisms and colon cancer susceptibility in Saudi Arabian female patients","year":2016,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Colorectal cancer; Internal medicine; Association (psychology); Cancer; Oncology; Psychology","score_opus":0.011239788867495772,"score_gpt":0.2406227111290439,"score_spread":0.22938292226154813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562421369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999448,0.00025709873,0.000050997118,0.000021467116,0.000002790067,0.0000017753866,0.00009952978,0.0000011145828,0.00011731658],"genre_scores_gemma":[0.9995509,0.0000907008,0.00007485638,0.000017760174,0.000005920106,0.0000021823844,0.000102285034,6.487814e-7,0.00015460716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998795,0.00002771723,0.000014765811,0.000037321377,0.00001771948,0.000022971446],"domain_scores_gemma":[0.9996613,0.00005342754,0.00019993803,0.000018702676,0.000032047767,0.000034565488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019609924,0.00023241033,0.00017012755,0.00032055945,0.00021052426,0.00022223977,0.000117988595,0.0002499667,0.002125849],"category_scores_gemma":[0.00047100414,0.00012150725,0.00025187386,0.0003263032,0.00010832005,0.00009660703,0.00014881705,0.0001831314,0.00016287286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044609056,0.000021201406,0.99445194,0.000026786705,0.00007557385,0.00018507503,0.000059023016,0.000045473775,0.002432423,0.00002207663,0.00006860516,0.002165694],"study_design_scores_gemma":[0.000015268912,0.00014327266,0.99766004,0.000010598902,0.000075826334,0.0009031868,0.00012694745,0.00024920536,0.000452437,0.000022096792,0.00033756916,0.0000036544109],"about_ca_topic_score_codex":0.0019057046,"about_ca_topic_score_gemma":0.0019398486,"teacher_disagreement_score":0.002125849,"about_ca_system_score_codex":0.000109512766,"about_ca_system_score_gemma":0.000101766476,"threshold_uncertainty_score":0.007111728},"labels":[],"label_agreement":null},{"id":"W2570540133","doi":"10.2147/ott.s124417","title":"RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thyroid cancer; Medicine; Breast cancer; Meta-analysis; Odds ratio; Methylation; Oncology; Publication bias; Thyroid; Internal medicine; Cancer; Gynecology; Biology; Genetics","score_opus":0.03230625972315221,"score_gpt":0.30201787895836035,"score_spread":0.26971161923520814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570540133","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06366746,0.92968124,0.0028959769,0.00055959093,0.00041580902,0.00025096437,0.0017979875,0.000108946326,0.00062204915],"genre_scores_gemma":[0.768366,0.2228101,0.0039444314,0.00078747916,0.00056402123,0.0007196207,0.001838842,0.00008823323,0.00088123616],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99434304,0.002472157,0.0011499985,0.0011070254,0.0006251355,0.00030255964],"domain_scores_gemma":[0.9916643,0.005721829,0.0010908155,0.00056612573,0.0007511994,0.00020584336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009232236,0.0028739255,0.010274264,0.004514172,0.0008392395,0.0025184338,0.0016878648,0.001943532,0.0032894427],"category_scores_gemma":[0.015449903,0.0014650899,0.052093863,0.0063605653,0.0004722542,0.001154441,0.0012674031,0.0017926883,0.00030401506],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031811716,0.00003169726,0.032453556,0.03579022,0.9208051,0.00023899262,0.00006702014,0.0011526045,0.0006367302,0.00007368905,0.0004254191,0.00514382],"study_design_scores_gemma":[0.00025563157,0.00014446037,0.010618091,0.0015816542,0.98585796,0.0001213667,0.000025501104,0.0005288564,0.00016304675,0.00011087183,0.00057482097,0.00001767291],"about_ca_topic_score_codex":0.0062558474,"about_ca_topic_score_gemma":0.009040133,"teacher_disagreement_score":0.010274264,"about_ca_system_score_codex":0.0013599714,"about_ca_system_score_gemma":0.0016740918,"threshold_uncertainty_score":0.048825324},"labels":[],"label_agreement":null},{"id":"W2583057834","doi":"10.2147/ott.s122774","title":"Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China; Qilu Hospital of Shandong University; Shandong University","keywords":"Hazard ratio; Meta-analysis; Medicine; Confidence interval; Internal medicine; Oncology; Publication bias; Lung cancer; Subgroup analysis; Malignancy; microRNA; Cancer; Biology; Gene","score_opus":0.0348696962660097,"score_gpt":0.31496434468289025,"score_spread":0.28009464841688053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583057834","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010978729,0.98617387,0.0011920844,0.0003227759,0.00026579044,0.00010047864,0.0006690314,0.00003762082,0.00025951906],"genre_scores_gemma":[0.44772074,0.5421016,0.0044267196,0.0014503329,0.0009473615,0.00063789764,0.0020139758,0.000089552246,0.0006118041],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99295527,0.0033893187,0.0016537104,0.0009245254,0.0007884755,0.00028875773],"domain_scores_gemma":[0.98941994,0.007424411,0.0015606642,0.0005560208,0.00085866207,0.00018022873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013053763,0.0030472698,0.013901844,0.0055208337,0.00049719523,0.0030519888,0.0017357657,0.0019211832,0.0025343685],"category_scores_gemma":[0.021073574,0.0013164607,0.048751473,0.006212416,0.0004422442,0.0014987241,0.0012517949,0.0019245314,0.0002869739],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030679866,0.000024242556,0.011809613,0.05643444,0.9170632,0.00015778806,0.00003995675,0.00085518113,0.00037346667,0.00009757077,0.000509942,0.009566539],"study_design_scores_gemma":[0.00031561137,0.00013104494,0.0051992214,0.0024405643,0.9904056,0.00009948812,0.0000145068825,0.00029529748,0.00008768282,0.00015449928,0.0008412338,0.000015177152],"about_ca_topic_score_codex":0.0033209124,"about_ca_topic_score_gemma":0.006036714,"teacher_disagreement_score":0.013901844,"about_ca_system_score_codex":0.0013831478,"about_ca_system_score_gemma":0.0016903565,"threshold_uncertainty_score":0.06903571},"labels":[],"label_agreement":null},{"id":"W2586120920","doi":"10.2147/ott.s111971","title":"Two SNPs in the promoter region of Toll-like receptor 4 gene are not associated with smoking in Saudi Arabia","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Single-nucleotide polymorphism; Genotype; TLR4; Saliva; Gene; SNP; Polymerase chain reaction; Biology; Polymorphism (computer science); Toll-like receptor; Population; Genetics; Immunology; Receptor; Medicine; Innate immune system; Internal medicine; Environmental health","score_opus":0.023291453695013554,"score_gpt":0.25611847112623537,"score_spread":0.2328270174312218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586120920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99973863,0.00007231429,0.00006404345,0.000018813285,0.0000017096014,0.0000012800501,0.000026494119,7.822058e-7,0.00007593607],"genre_scores_gemma":[0.9996984,0.000062998246,0.00007693961,0.000019710396,0.0000027769313,0.0000012768421,0.000054873002,9.4495016e-7,0.00008215579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997478,0.000067568675,0.000047741094,0.000057428304,0.000046516,0.00003295787],"domain_scores_gemma":[0.9995753,0.0001031185,0.00017567599,0.00003699645,0.0000642464,0.000044747867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039424587,0.0002176021,0.00022879729,0.0003560255,0.00027089365,0.00033668434,0.00022250776,0.00028003924,0.0013465072],"category_scores_gemma":[0.0007064493,0.00015217386,0.00029518726,0.00037802386,0.00022316856,0.00012461617,0.00020629851,0.0002032951,0.00015053597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086020137,0.000084894455,0.9737191,0.00004133434,0.00016941696,0.0005448856,0.0006150802,0.000109039276,0.015605943,0.000119944816,0.000104889354,0.008025123],"study_design_scores_gemma":[0.00005625726,0.00034748335,0.9921749,0.000023478056,0.00019980305,0.002153505,0.00080942386,0.0008205561,0.002523053,0.00010680946,0.00077325676,0.000011425596],"about_ca_topic_score_codex":0.004147018,"about_ca_topic_score_gemma":0.0030333975,"teacher_disagreement_score":0.004147018,"about_ca_system_score_codex":0.00016931079,"about_ca_system_score_gemma":0.0002728946,"threshold_uncertainty_score":0.008245766},"labels":[],"label_agreement":null},{"id":"W2592172886","doi":"10.2147/ott.s112165","title":"Toll-like receptor-4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Breast cancer; Medicine; Estrogen receptor; Toll-like receptor; Oncology; Receptor; Internal medicine; Estrogen; Cancer; Innate immune system","score_opus":0.019198467815052953,"score_gpt":0.32422625563115176,"score_spread":0.3050277878160988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592172886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944,0.00032333864,0.000025214717,0.000026136024,0.000004270423,0.000001690862,0.000096709526,6.5840624e-7,0.000081939594],"genre_scores_gemma":[0.9996302,0.00010731052,0.00003386476,0.000013145747,0.0000051836555,0.000001711176,0.00012140538,4.483905e-7,0.00008678991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984264,0.000048401165,0.00002282157,0.00002897175,0.00003273844,0.00002443995],"domain_scores_gemma":[0.99940896,0.00011239205,0.00026546212,0.00003275818,0.000101277124,0.0000792146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035625565,0.0002239709,0.00019666359,0.00043068576,0.00018057125,0.00028566553,0.00019477858,0.0002716315,0.0013601519],"category_scores_gemma":[0.0008636753,0.00010369489,0.00028366313,0.0004427987,0.00011717314,0.00012526798,0.0002294273,0.00023823419,0.000162197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023089371,0.000013064249,0.99776065,0.000013718297,0.000042650878,0.000049849383,0.0000265078,0.000024163264,0.0006126221,0.000006823392,0.000036859266,0.0011821769],"study_design_scores_gemma":[0.0000142737745,0.00012140139,0.9984189,0.000009713458,0.00007266692,0.00039039602,0.00015053074,0.00031264135,0.000272352,0.000021094065,0.00021278788,0.0000031912548],"about_ca_topic_score_codex":0.0025461246,"about_ca_topic_score_gemma":0.0023636466,"teacher_disagreement_score":0.0025461246,"about_ca_system_score_codex":0.00016419172,"about_ca_system_score_gemma":0.00021133435,"threshold_uncertainty_score":0.0050626397},"labels":[],"label_agreement":null},{"id":"W2592982225","doi":"10.2147/ott.s131611","title":"<em>GSTM1 </em>polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Funnel plot; Publication bias; Internal medicine; Odds ratio; Medicine; Confidence interval; Genotype; Subgroup analysis; Nasopharyngeal cancer; Oncology; Population; Gastroenterology; Nasopharyngeal carcinoma; Genetics; Biology; Gene","score_opus":0.10439801246588071,"score_gpt":0.37823501658510494,"score_spread":0.27383700411922424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592982225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02893227,0.9675252,0.0011964962,0.00047104838,0.0002684539,0.00027015255,0.00083182217,0.00005117975,0.00045333387],"genre_scores_gemma":[0.46645352,0.5247387,0.0038032627,0.00093421433,0.0006232585,0.0010470828,0.001543859,0.000055605247,0.00080030836],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99552155,0.0017500869,0.0011811296,0.0007067252,0.00059294037,0.00024751283],"domain_scores_gemma":[0.99171364,0.005675654,0.0014203133,0.00041017155,0.0006038453,0.00017630948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008256997,0.0027769066,0.012316276,0.0052623847,0.0007488304,0.003003833,0.0018135105,0.0022557578,0.0029939332],"category_scores_gemma":[0.015389168,0.0013512399,0.043997336,0.0066370023,0.0005540597,0.001384734,0.0012565539,0.0017100624,0.0002927467],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038915947,0.00005770108,0.02013162,0.10873563,0.8549492,0.0003543567,0.00009990354,0.0011645155,0.0006508384,0.00011904832,0.00058608456,0.009259516],"study_design_scores_gemma":[0.0003212046,0.00018432303,0.0078429645,0.003870842,0.9863516,0.00012087877,0.000026511918,0.00030100744,0.0001338191,0.00013036934,0.0006989548,0.000017496888],"about_ca_topic_score_codex":0.004737241,"about_ca_topic_score_gemma":0.008793864,"teacher_disagreement_score":0.012316276,"about_ca_system_score_codex":0.0016014369,"about_ca_system_score_gemma":0.0022374017,"threshold_uncertainty_score":0.043667734},"labels":[],"label_agreement":null},{"id":"W2593100475","doi":"10.2147/ott.s116136","title":"Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Adenocarcinoma; CA19-9; Cohort; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Oncology; Internal medicine; Radiology; Cancer","score_opus":0.01659291495249782,"score_gpt":0.2877013388438612,"score_spread":0.27110842389136336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593100475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953103,0.00018547007,0.00006599581,0.000022345383,0.0000076631095,0.0000049349323,0.00009778154,0.0000039006823,0.00008093089],"genre_scores_gemma":[0.9993468,0.00012321139,0.000049065566,0.000021436672,0.000015407983,0.000005493687,0.00029363972,0.0000022952538,0.00014264787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976605,0.00005262892,0.000021835758,0.00008358927,0.000037270376,0.00003860879],"domain_scores_gemma":[0.9993037,0.00014155287,0.00018224434,0.00013046681,0.00007918949,0.00016282692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006663437,0.0003807389,0.00055363413,0.00028984345,0.0003671306,0.00059195515,0.00023019002,0.0003608593,0.00079668366],"category_scores_gemma":[0.0014726985,0.00025692876,0.0007861055,0.00040831897,0.00024146176,0.00048130596,0.00039351967,0.00063320267,0.00027064374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033474744,0.0004803904,0.9873531,0.0000127341045,0.00026915112,0.00019396823,0.000112778376,0.00014542878,0.0011235133,0.0000074062837,0.00021962528,0.0067345425],"study_design_scores_gemma":[0.00014168984,0.001975143,0.9958467,0.00000479792,0.00030964796,0.00037813158,0.00011875425,0.0005116511,0.00033010205,0.00003158225,0.0003391829,0.000012627557],"about_ca_topic_score_codex":0.001359107,"about_ca_topic_score_gemma":0.0015348529,"teacher_disagreement_score":0.001359107,"about_ca_system_score_codex":0.00021078074,"about_ca_system_score_gemma":0.00025836236,"threshold_uncertainty_score":0.003524065},"labels":[],"label_agreement":null},{"id":"W2601936575","doi":"10.2147/ott.s127833","title":"Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Society for Radiation Oncology","keywords":"Cosmesis; Medicine; Breast cancer; Radiation therapy; Univariate analysis; Multivariate analysis; Nuclear medicine; Toxicity; Internal medicine; Oncology; Radiology; Surgery; Cancer","score_opus":0.01605708494908665,"score_gpt":0.26320694115313487,"score_spread":0.24714985620404822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601936575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98928666,0.0028733062,0.0016088523,0.00045633575,0.00005723269,0.0002117027,0.0020458524,0.000031787873,0.0034283039],"genre_scores_gemma":[0.99756575,0.00023074493,0.00037185886,0.0000706036,0.000014364292,0.000046473695,0.0010736138,0.000010936775,0.0006156068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984156,0.0006986547,0.000066330686,0.00020274128,0.00045928202,0.00015738797],"domain_scores_gemma":[0.99752146,0.0009771353,0.00060080143,0.0003426876,0.0003047697,0.00025316273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036450394,0.0003653874,0.000537142,0.00021225822,0.00052915985,0.00059446774,0.0006108883,0.00039317395,0.0015769483],"category_scores_gemma":[0.007334892,0.00014959114,0.0011899219,0.00056961895,0.0002937196,0.00021691725,0.00036448546,0.0004704496,0.0001072362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017146282,0.00007112262,0.9287134,0.00024176396,0.0010462905,0.00010069585,0.00014541844,0.0069960966,0.0011201854,0.0004549736,0.002415493,0.041548293],"study_design_scores_gemma":[0.0006044373,0.0010015967,0.98508155,0.00005165901,0.0009159758,0.00015478967,0.000049274997,0.007029694,0.00030474912,0.00030564266,0.0044770963,0.000023607998],"about_ca_topic_score_codex":0.3523021,"about_ca_topic_score_gemma":0.4884732,"teacher_disagreement_score":0.3523021,"about_ca_system_score_codex":0.004002032,"about_ca_system_score_gemma":0.0052550337,"threshold_uncertainty_score":0.700503},"labels":[],"label_agreement":null},{"id":"W2607856708","doi":"10.2147/ott.s121618","title":"No genetic relationship between <em>TLR2</em> rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Breast cancer; Medicine; Gene; Cancer; Oncology; Biology; Genetics; Internal medicine","score_opus":0.027574646184753974,"score_gpt":0.27573385777176,"score_spread":0.24815921158700605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607856708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990534,0.00029544876,0.00008315612,0.000053006715,0.0000073832284,0.0000028937495,0.00021496054,0.0000017468519,0.000287938],"genre_scores_gemma":[0.9993734,0.00007177705,0.000071775685,0.000025032674,0.000007570283,0.000003524076,0.00017984961,0.0000014828249,0.0002655456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997868,0.00004283775,0.000031180196,0.000074838295,0.000035563728,0.000028812174],"domain_scores_gemma":[0.99943167,0.00014981639,0.00023793847,0.000051790026,0.000056115125,0.000072619194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002647606,0.00029811414,0.00017008747,0.00029859174,0.00024795832,0.0002872145,0.00021492504,0.0003417766,0.0049457042],"category_scores_gemma":[0.00095839176,0.00015031423,0.0003828689,0.00038421844,0.0001783762,0.00014168413,0.00019087357,0.00025429577,0.00030751753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010845894,0.000041554697,0.9879624,0.000051902916,0.000280278,0.0003793261,0.00019166162,0.00007719504,0.0056817746,0.0000765364,0.00021651515,0.0039563705],"study_design_scores_gemma":[0.0000415088,0.00018501944,0.9955318,0.000018966633,0.00022524883,0.0014753737,0.00016573824,0.0005175896,0.00078149186,0.000093132054,0.00095666375,0.000007400833],"about_ca_topic_score_codex":0.003076139,"about_ca_topic_score_gemma":0.0030685398,"teacher_disagreement_score":0.0049457042,"about_ca_system_score_codex":0.00013988503,"about_ca_system_score_gemma":0.000168889,"threshold_uncertainty_score":0.016544998},"labels":[],"label_agreement":null},{"id":"W2611131904","doi":"10.2147/ott.s133563","title":"Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University","keywords":"Multicellular organism; Peptide; Chemistry; Computational biology; Biochemistry; Biology; Cell","score_opus":0.018628017103646914,"score_gpt":0.2953789955439952,"score_spread":0.2767509784403483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611131904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506515,0.00042739598,0.0033126487,0.00003815756,0.0000122759975,0.0000230319,0.00013525385,0.000055935107,0.000930187],"genre_scores_gemma":[0.99559313,0.0003658907,0.0030935016,0.0000277625,0.000004204177,0.000015731639,0.0001995502,0.00001673534,0.00068365113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999398,0.000008142972,0.000006179228,0.000016329077,0.00001462172,0.000014829219],"domain_scores_gemma":[0.99994576,0.000008605987,0.000023419278,0.000006920171,0.000004875825,0.000010506091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007701079,0.00024346836,0.00009953146,0.00007808988,0.00006368013,0.00018147606,0.00009610928,0.00019069713,0.0005425543],"category_scores_gemma":[0.00008148046,0.00008879012,0.0002158072,0.0000796642,0.00009896645,0.00015342994,0.00015014202,0.0002484714,0.00023397023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017036102,0.0000053935896,0.000051579525,0.000013942784,0.0000022954541,0.00002956299,0.0000063329853,0.0000884267,0.9992853,0.00002581837,0.00001556816,0.00045879302],"study_design_scores_gemma":[0.0000050904246,0.00009181024,0.0009662058,0.0000020055552,0.000004738065,0.00012428632,0.0000054874313,0.0007856508,0.99711573,0.0000071913123,0.00088908477,0.000002780391],"about_ca_topic_score_codex":0.00032136973,"about_ca_topic_score_gemma":0.0004438848,"teacher_disagreement_score":0.0005425543,"about_ca_system_score_codex":0.00018321557,"about_ca_system_score_gemma":0.00009164881,"threshold_uncertainty_score":0.001815021},"labels":[],"label_agreement":null},{"id":"W2612006186","doi":"10.2147/ott.s104177","title":"New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Afatinib; Medicine; Nivolumab; Lung cancer; Pembrolizumab; Ramucirumab; Oncology; Docetaxel; Context (archaeology); Squamous-cell carcinoma of the lung; Internal medicine; Chemotherapy; Cancer; Intensive care medicine; Immunotherapy; Epidermal growth factor receptor; Erlotinib","score_opus":0.05241281530813648,"score_gpt":0.4199899764586437,"score_spread":0.36757716115050726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2612006186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105258354,0.9984175,0.000090146765,0.0003093597,0.00016540808,0.0000037075008,0.000017213495,0.000006520577,0.0008849242],"genre_scores_gemma":[0.00078311475,0.9982797,0.00013613836,0.0002369145,0.00012736325,0.000004288854,0.000028270668,0.0000016210242,0.00040270432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997974,0.000036448448,0.00003672269,0.00003652942,0.000071947194,0.000020928648],"domain_scores_gemma":[0.9997397,0.00013947656,0.000036377278,0.00000759057,0.000054674732,0.00002218348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048245408,0.0005654182,0.001133967,0.0019225734,0.0002696979,0.00086268666,0.0007069427,0.00081091374,0.003721652],"category_scores_gemma":[0.0006189257,0.00021167858,0.00064430584,0.0017329406,0.00039823377,0.0012824599,0.0006572526,0.002268564,0.0016922799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007266154,0.00006196529,0.00010574138,0.013032164,0.00009814038,0.00014766108,0.000049822807,0.000343507,0.0011772765,0.0037345323,0.019269342,0.9619072],"study_design_scores_gemma":[0.000030716958,0.00010648404,0.00041350903,0.0028448615,0.00011320119,0.0009351326,0.000040084517,0.00008813084,0.00037831414,0.0017883099,0.993248,0.000013146121],"about_ca_topic_score_codex":0.00067878055,"about_ca_topic_score_gemma":0.0017715794,"teacher_disagreement_score":0.003721652,"about_ca_system_score_codex":0.0005083324,"about_ca_system_score_gemma":0.0008654523,"threshold_uncertainty_score":0.012450159},"labels":[],"label_agreement":null},{"id":"W2616754233","doi":"10.2147/ott.s136484","title":"The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Nelfinavir; Protease inhibitor (pharmacology); Refractory (planetary science); Medicine; Leukemia; Human immunodeficiency virus (HIV); Protease; Pharmacology; Virology; Immunology; Chemistry; Antiretroviral therapy; Biology; Enzyme; Viral load","score_opus":0.034973207282945014,"score_gpt":0.2994211456358922,"score_spread":0.2644479383529472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616754233","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.294755,0.6851922,0.005590786,0.0022610046,0.00045470652,0.00018127314,0.00041097534,0.00020126223,0.010952711],"genre_scores_gemma":[0.66968924,0.3151426,0.009473163,0.0010961046,0.0003664909,0.000115894676,0.00062512234,0.000022567987,0.0034687724],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999379,0.00001526206,0.0000060682232,0.000011255726,0.000018224326,0.000011312125],"domain_scores_gemma":[0.9999639,0.000006019423,0.000012912895,0.0000029012358,0.0000055798128,0.0000086692335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022667673,0.0002824571,0.00029425073,0.00043456318,0.00014447738,0.00043035788,0.0002799885,0.00023938791,0.00077172],"category_scores_gemma":[0.000104492654,0.0000703225,0.0002498254,0.00029840478,0.0001857328,0.0002865993,0.00019739685,0.00053085625,0.00017432345],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017098777,0.0007545972,0.003487294,0.0020252957,0.000147217,0.0018153354,0.00015948464,0.0012831613,0.19610351,0.0031595463,0.005521512,0.7838332],"study_design_scores_gemma":[0.0030458774,0.018938158,0.0324015,0.0015828394,0.0010107061,0.0377839,0.00031823906,0.007416473,0.24059942,0.0034331295,0.6533422,0.00012754042],"about_ca_topic_score_codex":0.00023728728,"about_ca_topic_score_gemma":0.0010864706,"teacher_disagreement_score":0.00077172,"about_ca_system_score_codex":0.00027225452,"about_ca_system_score_gemma":0.0002651848,"threshold_uncertainty_score":0.0025817156},"labels":[],"label_agreement":null},{"id":"W2646737791","doi":"10.2147/ott.s127317","title":"The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Prostate cancer; Prostatectomy; Hazard ratio; Internal medicine; Confidence interval; Oncology; Publication bias; MEDLINE; Urology; Cancer","score_opus":0.15697010279596987,"score_gpt":0.4731653371547831,"score_spread":0.31619523435881325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2646737791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005845496,0.9926622,0.00042771557,0.00017722172,0.00011973126,0.0001682457,0.000419462,0.000017581364,0.00016234221],"genre_scores_gemma":[0.20124534,0.7933908,0.0020181022,0.0007663374,0.00032950458,0.00094246725,0.00097180496,0.00002531668,0.0003103582],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9928678,0.0031640865,0.0021221663,0.0008517051,0.000768213,0.00022601862],"domain_scores_gemma":[0.9861712,0.009759439,0.0023548058,0.00045897922,0.0010455293,0.00020987172],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010540489,0.0023607912,0.01733143,0.0051432913,0.00063676265,0.0029458671,0.0018746369,0.0018543369,0.0031309624],"category_scores_gemma":[0.021400778,0.0012159415,0.03546835,0.007984006,0.0006938253,0.001530923,0.0012565467,0.001793063,0.00025076038],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014981345,0.000026912569,0.00736853,0.32530135,0.6563702,0.00013780752,0.00006874594,0.00048879423,0.000186624,0.0000980194,0.0004812897,0.007973616],"study_design_scores_gemma":[0.0002734132,0.00013096847,0.0043070815,0.013665012,0.9803074,0.00007296588,0.000027674365,0.00019983014,0.00007588871,0.000122010046,0.00079936127,0.000018448925],"about_ca_topic_score_codex":0.005483111,"about_ca_topic_score_gemma":0.011706265,"teacher_disagreement_score":0.9826686,"about_ca_system_score_codex":0.0018338277,"about_ca_system_score_gemma":0.0031801397,"threshold_uncertainty_score":0.055744052},"labels":[],"label_agreement":null},{"id":"W2736563947","doi":"10.2147/ott.s142087","title":"Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Everolimus; Exploratory analysis; Medicine; Computer science; Medical physics; Oncology; Data science","score_opus":0.05140317221473301,"score_gpt":0.39460928105628057,"score_spread":0.34320610884154756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736563947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931288,0.0040503168,0.00045886385,0.00016904372,0.000024188232,0.00023490444,0.0009235632,0.0000153225,0.0009951086],"genre_scores_gemma":[0.9973482,0.00056773523,0.00030408648,0.00013586199,0.00004162385,0.00016878621,0.0008683205,0.000010224955,0.0005551318],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99710816,0.0018663666,0.00013187998,0.00026982217,0.00032656547,0.00029729388],"domain_scores_gemma":[0.9964393,0.0018518376,0.00081902294,0.00035381792,0.00014197522,0.000394023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004842424,0.00092096184,0.0021028346,0.00032148525,0.00027873617,0.00096074044,0.00076131633,0.00056889164,0.0035733415],"category_scores_gemma":[0.0040991874,0.00025508594,0.005357136,0.00046342096,0.00054263475,0.00059699785,0.0006988571,0.0012129453,0.00038748354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79386556,0.0046038153,0.10590633,0.0018698659,0.0395351,0.0005628117,0.00025098512,0.0032390896,0.008638581,0.00037667956,0.0014863771,0.039664865],"study_design_scores_gemma":[0.08637215,0.25923926,0.55999064,0.000351977,0.065603144,0.0014816355,0.0003924487,0.007046761,0.007223098,0.00154893,0.0106099555,0.00014005085],"about_ca_topic_score_codex":0.00037792532,"about_ca_topic_score_gemma":0.00080771674,"teacher_disagreement_score":0.004842424,"about_ca_system_score_codex":0.0005981255,"about_ca_system_score_gemma":0.00084815675,"threshold_uncertainty_score":0.025609553},"labels":[],"label_agreement":null},{"id":"W2741932379","doi":"10.2147/ott.s133699","title":"A practical guide to the handling and administration of talimogene laherparepvec in Europe","year":2017,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Rosetrees Trust; National Institute for Health and Care Research; Amgen","keywords":"Medicine; Oncolytic virus; Vial; Patient care; Herpes simplex virus; Internal medicine; Virus; Cancer; Virology; Nursing","score_opus":0.1262670155319251,"score_gpt":0.45647096414096927,"score_spread":0.3302039486090442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741932379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011361872,0.39511824,0.21008387,0.016635418,0.008386284,0.0050221877,0.015306646,0.0228883,0.3151973],"genre_scores_gemma":[0.02675175,0.36528075,0.2716277,0.019295163,0.0028728948,0.006444016,0.02358109,0.0044102,0.27973643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991685,0.00021558708,0.0001181224,0.00009066826,0.0003548743,0.00005227128],"domain_scores_gemma":[0.9991757,0.00031010143,0.000118190634,0.000065739216,0.0002554301,0.00007483564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020513828,0.0010073876,0.0009870398,0.0018440639,0.00047563005,0.0014589292,0.0011517698,0.0016274196,0.046541877],"category_scores_gemma":[0.0027031782,0.00053594704,0.0006020249,0.0011477562,0.00044236606,0.0016422934,0.0007779381,0.0020153853,0.05709419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028442842,0.00023455871,0.0006426966,0.002491559,0.000024699704,0.00069612364,0.00025148963,0.00042733326,0.015202035,0.004196752,0.38002393,0.5955245],"study_design_scores_gemma":[0.000020828418,0.00011702067,0.00033230797,0.00034583377,0.00001016868,0.0008504728,0.000039696024,0.00014009107,0.0015327911,0.00058782875,0.996009,0.000013904706],"about_ca_topic_score_codex":0.0010998548,"about_ca_topic_score_gemma":0.0019359196,"teacher_disagreement_score":0.046541877,"about_ca_system_score_codex":0.0004107855,"about_ca_system_score_gemma":0.0012947447,"threshold_uncertainty_score":0.15569806},"labels":[],"label_agreement":null},{"id":"W2750210114","doi":"10.2147/ott.s143315","title":"miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Natural Science Foundation of China","keywords":"Microvesicles; Mesenchymal stem cell; Cancer research; microRNA; Metastasis; Bone marrow; Cancer; Medicine; Transfection; Cancer cell; Exosome; Pathology; Immunology; Biology; Cell culture; Internal medicine","score_opus":0.01692403822953294,"score_gpt":0.2815639050798786,"score_spread":0.2646398668503457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750210114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880238,0.0056698234,0.0037493727,0.00016264577,0.00007199935,0.000046199573,0.0002463647,0.00008312379,0.001946654],"genre_scores_gemma":[0.99437743,0.0023563916,0.0013476029,0.0000694713,0.000012861885,0.000031340714,0.00030920614,0.000014577052,0.0014810718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999182,0.000015473383,0.000010195943,0.000012241621,0.000028614926,0.00001518745],"domain_scores_gemma":[0.9999615,0.0000066102193,0.000009183247,0.00000301832,0.000009024421,0.000010584519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012259145,0.00017440575,0.00021138694,0.00020198975,0.00013811205,0.0002691102,0.00005172038,0.00015603933,0.0005949708],"category_scores_gemma":[0.00015897828,0.000083236635,0.00017924712,0.00010987469,0.00012723943,0.00012956471,0.00022030747,0.00023523404,0.00020235486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028820234,0.000043687014,0.0011480862,0.00014834267,0.000015611171,0.00018999934,0.00004253568,0.00013885187,0.99080735,0.00032480687,0.00017412007,0.006678376],"study_design_scores_gemma":[0.000033508713,0.00037778355,0.012097925,0.000019765259,0.00005786265,0.00074847706,0.000066222914,0.0016569202,0.9753924,0.00016968431,0.00937232,0.00000701801],"about_ca_topic_score_codex":0.0002285995,"about_ca_topic_score_gemma":0.00025954944,"teacher_disagreement_score":0.0005949708,"about_ca_system_score_codex":0.00013246256,"about_ca_system_score_gemma":0.00022872465,"threshold_uncertainty_score":0.001990378},"labels":[],"label_agreement":null},{"id":"W2769939168","doi":"10.2147/ott.s145776","title":"The relationship between <em>IGF2BP2</em> and <em>PPARG</em> polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Science Foundation of Fujian Province; Fujian Medical University; Jiangsu University; Centre in Green Chemistry and Catalysis","keywords":"Peroxisome proliferator-activated receptor gamma; Internal medicine; Medicine; Population; Genotyping; Esophageal squamous cell carcinoma; Oncology; Gastroenterology; Genotype; Biology; Genetics; Carcinoma; Gene; Peroxisome proliferator-activated receptor; Receptor; Environmental health","score_opus":0.023904805619880804,"score_gpt":0.2894256535990162,"score_spread":0.2655208479791354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769939168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993789,0.00015860322,0.0001452639,0.00002729087,0.0000059495005,0.000004455809,0.000095133204,0.0000022405043,0.00018200482],"genre_scores_gemma":[0.9995283,0.000038261696,0.0000886283,0.00001882986,0.000009134383,0.000004048023,0.000080344835,0.0000010652337,0.00023139123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979466,0.00003834028,0.000024852936,0.000070358416,0.000043234842,0.000028497643],"domain_scores_gemma":[0.9997329,0.00005321676,0.00010129585,0.000035661596,0.000029971994,0.00004702691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038794015,0.00030292198,0.00018157472,0.00035461533,0.0002965214,0.0002635756,0.00021927893,0.00026997368,0.0017642665],"category_scores_gemma":[0.00050123566,0.00017206681,0.00033167176,0.0004383681,0.00021388163,0.00014298924,0.00015976834,0.00026518933,0.00014106213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005902202,0.000052324885,0.9918873,0.000018430033,0.00020900811,0.00039431523,0.00007434015,0.00006788076,0.0042502484,0.000061840736,0.000113723014,0.002280318],"study_design_scores_gemma":[0.00001894242,0.00006759957,0.9982514,0.000002404972,0.00011129756,0.0004198626,0.000040349267,0.00039594455,0.00041907333,0.000053622636,0.00021594863,0.0000035041694],"about_ca_topic_score_codex":0.004689695,"about_ca_topic_score_gemma":0.004871981,"teacher_disagreement_score":0.004689695,"about_ca_system_score_codex":0.00020332226,"about_ca_system_score_gemma":0.00022092253,"threshold_uncertainty_score":0.009324789},"labels":[],"label_agreement":null},{"id":"W2770086290","doi":"10.2147/ott.s151260","title":"Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Male Breast Health Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"Dalian Medical University","keywords":"Medicine; Occult; Breast cancer; Dermatomyositis; Prophylactic Mastectomy; Modified Radical Mastectomy; Mastectomy; Lymph node; Cancer; Immunohistochemistry; Dermatology; Pathology; Internal medicine","score_opus":0.015132958256609085,"score_gpt":0.32515894784137017,"score_spread":0.3100259895847611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770086290","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21895824,0.7620252,0.002937563,0.0028642183,0.0013146405,0.000141904,0.0003775938,0.00017083394,0.011209827],"genre_scores_gemma":[0.5150847,0.47193,0.0026846637,0.0023677256,0.004256684,0.000053757543,0.0003558669,0.000039578077,0.003227051],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996445,0.000031431453,0.00011368644,0.00008441918,0.00007178597,0.000054238084],"domain_scores_gemma":[0.9993699,0.00016323577,0.00027150245,0.00003732072,0.000055401324,0.00010266091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002725615,0.0009988953,0.00104536,0.0040014996,0.0008547996,0.0012310916,0.0009133483,0.0016095028,0.0024884369],"category_scores_gemma":[0.0007716542,0.00043418803,0.000544074,0.004085857,0.0009721521,0.0016272971,0.00073799974,0.000773162,0.0010563784],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053608223,0.0001285407,0.021689706,0.0025957024,0.00015479984,0.9134134,0.00049469573,0.00016311297,0.002377815,0.00033485226,0.0062609217,0.052332718],"study_design_scores_gemma":[0.0000050049807,0.000026897522,0.006962363,0.00034732738,0.00010419608,0.9832478,0.00031463624,0.00008262926,0.0002542312,0.00015694986,0.008480552,0.000017483766],"about_ca_topic_score_codex":0.0009659997,"about_ca_topic_score_gemma":0.0017984599,"teacher_disagreement_score":0.0040014996,"about_ca_system_score_codex":0.00037370675,"about_ca_system_score_gemma":0.00052375573,"threshold_uncertainty_score":0.008324623},"labels":[],"label_agreement":null},{"id":"W2775292267","doi":"10.2147/ott.s150092","title":"<em>Hopea odorata </em>extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Bioactive natural compounds","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Propidium iodide; Apoptosis; IC50; Annexin; Cytotoxicity; Flow cytometry; Chemistry; Molecular biology; Pharmacology; Traditional medicine; Biochemistry; Biology; In vitro; Programmed cell death; Medicine","score_opus":0.019875542180613073,"score_gpt":0.25414810861660075,"score_spread":0.23427256643598768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775292267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948133,0.003794346,0.0016507041,0.0002345393,0.00008463973,0.00007710064,0.0008934453,0.00019884203,0.0035850066],"genre_scores_gemma":[0.99096304,0.0022993041,0.0017184285,0.00013716155,0.000035631783,0.00004622107,0.0010397659,0.000021140026,0.0037393644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995613,0.000006717866,0.000005637842,0.000006321754,0.00001313924,0.000012083974],"domain_scores_gemma":[0.9999598,0.0000067300875,0.000009564061,0.0000037944178,0.000006734396,0.000013424582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000818656,0.0004064793,0.00025260833,0.000418562,0.000106840285,0.00012190961,0.00013131247,0.00018915458,0.00246484],"category_scores_gemma":[0.00006817537,0.00009557636,0.00031160473,0.00017252401,0.00014715396,0.00017017362,0.00016063232,0.00043630463,0.00040930088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061867514,0.00024112103,0.0002827256,0.00020136852,0.0000143737325,0.00009438402,0.000010811768,0.00005775382,0.9940897,0.000057412133,0.00012981641,0.0042019202],"study_design_scores_gemma":[0.00028615163,0.0044674072,0.017598316,0.00004357081,0.00009104385,0.00059456803,0.000059484984,0.0007169264,0.9707738,0.00012170552,0.005234637,0.000012333212],"about_ca_topic_score_codex":0.0005817547,"about_ca_topic_score_gemma":0.0007565536,"teacher_disagreement_score":0.00246484,"about_ca_system_score_codex":0.000115260875,"about_ca_system_score_gemma":0.00019045963,"threshold_uncertainty_score":0.008245707},"labels":[],"label_agreement":null},{"id":"W2782520798","doi":"10.2147/ott.s114276","title":"miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Yang-Ming University; Beef Cattle Research Council; National Science Council","keywords":"Suppressor; Apoptosis; PI3K/AKT/mTOR pathway; Cancer research; Urothelial carcinoma; Human bladder; Urinary bladder; Medicine; Urology; Chemistry; Internal medicine; Bladder cancer; Cancer; Biochemistry","score_opus":0.012346080907464302,"score_gpt":0.2756773129436678,"score_spread":0.2633312320362035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782520798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980962,0.005950518,0.006323625,0.00031923808,0.00016833242,0.00011996504,0.00142037,0.00041268184,0.0043234043],"genre_scores_gemma":[0.9859578,0.00220278,0.006044099,0.00014643153,0.000025984215,0.00014593257,0.0024282003,0.000042071653,0.0030066697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996948,0.000043540425,0.000044614466,0.000051994957,0.00012679238,0.00003826913],"domain_scores_gemma":[0.99990404,0.000021922322,0.000028621671,0.000013374826,0.000017042019,0.000014978338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025809326,0.00045373835,0.0004502862,0.0004364103,0.00025309314,0.00037945673,0.0002688276,0.00035373692,0.0016072501],"category_scores_gemma":[0.00022214824,0.00020036449,0.0005643301,0.00039042294,0.0002775349,0.00018874633,0.00022527282,0.00073458266,0.0007305326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004029364,0.0001618965,0.0005208967,0.00017896383,0.000026773,0.00016444633,0.000039119037,0.00021386427,0.9934163,0.00014653846,0.00029133566,0.004436955],"study_design_scores_gemma":[0.00003374323,0.0005279788,0.0028227393,0.0000101461155,0.000044839053,0.0003429203,0.000025630154,0.0011374657,0.9915531,0.00003377613,0.0034616834,0.0000060705283],"about_ca_topic_score_codex":0.00039493124,"about_ca_topic_score_gemma":0.00047561078,"teacher_disagreement_score":0.0016072501,"about_ca_system_score_codex":0.00033151652,"about_ca_system_score_gemma":0.00033409795,"threshold_uncertainty_score":0.005376756},"labels":[],"label_agreement":null},{"id":"W2783139321","doi":"10.2147/ott.s155511","title":"Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Associated Medical Services","funders":"Thailand Research Fund; Khon Kaen University","keywords":"Cell growth; Motility; PI3K/AKT/mTOR pathway; Annexin; Cyclin D1; Vimentin; Apoptosis; Protein kinase B; Cancer research; Gene knockdown; Cell cycle; Biology; Cell biology; Signal transduction; Chemistry; Immunology; Immunohistochemistry; Biochemistry","score_opus":0.02006550453381741,"score_gpt":0.2687902656443901,"score_spread":0.2487247611105727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783139321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931519,0.0040200423,0.00062081096,0.00017196951,0.00002031434,0.000016985865,0.00015914912,0.000056249322,0.0017825115],"genre_scores_gemma":[0.9956644,0.0022472106,0.0004762799,0.00007114511,0.0000073926412,0.000030126512,0.00019563365,0.000006856717,0.0013010087],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993205,0.000016098715,0.00000525675,0.0000074178874,0.00001495388,0.000024310442],"domain_scores_gemma":[0.999967,0.000003892686,0.000009901445,0.0000025040604,0.000004568331,0.000012142907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077986886,0.00022127056,0.00017752562,0.00024577384,0.00012809708,0.00017469785,0.00008218896,0.00011940429,0.0006851664],"category_scores_gemma":[0.000080472084,0.000078440586,0.00019514239,0.00012689666,0.0001358015,0.00011748541,0.00013861922,0.00034947574,0.00015493554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000609029,0.000070172624,0.0025442876,0.00018934614,0.000029246807,0.00038054827,0.000033709002,0.00020225941,0.98933333,0.0001448596,0.00020452202,0.006258708],"study_design_scores_gemma":[0.000102719074,0.0012607911,0.080177404,0.000027434484,0.00014176624,0.0013692351,0.00014358076,0.0026477985,0.9068076,0.00021970258,0.007084555,0.00001738689],"about_ca_topic_score_codex":0.0005463671,"about_ca_topic_score_gemma":0.00093447947,"teacher_disagreement_score":0.0006851664,"about_ca_system_score_codex":0.00019024799,"about_ca_system_score_gemma":0.00021052967,"threshold_uncertainty_score":0.0022920966},"labels":[],"label_agreement":null},{"id":"W2783821295","doi":"10.2147/ott.s153682","title":"Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Second Military Medical University; Natural Science Foundation of Fujian Province","keywords":"Pooled analysis; Medicine; Oncology; Internal medicine; Cancer research; Meta-analysis","score_opus":0.008153278812322048,"score_gpt":0.2903859823246057,"score_spread":0.2822327035122837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783821295","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.122631826,0.8680732,0.0019685612,0.00023927155,0.0002133146,0.00035909633,0.0058399905,0.00005058772,0.0006241305],"genre_scores_gemma":[0.8612862,0.12884107,0.0024676,0.00047675156,0.0002871994,0.0009010908,0.0052148,0.000037470923,0.00048776448],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99534684,0.0016582594,0.0015278569,0.0007432317,0.0004960911,0.00022761604],"domain_scores_gemma":[0.99265224,0.0044075144,0.0017582732,0.00045491,0.0006109364,0.000116087984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008397041,0.0019068633,0.008492162,0.0038008618,0.0004211419,0.0013839666,0.0008293616,0.0012798236,0.0018703297],"category_scores_gemma":[0.012030837,0.0007560981,0.024949845,0.005101098,0.00034517207,0.00083605293,0.0008874667,0.0007599207,0.00020589547],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012176466,0.0000553886,0.06879911,0.06749436,0.83429813,0.00031410618,0.00008620679,0.000981135,0.0009517452,0.00008067945,0.0007795644,0.013983127],"study_design_scores_gemma":[0.0010847552,0.00061665714,0.04328487,0.0029536956,0.9496013,0.00023728561,0.00005135745,0.00034065987,0.00031166046,0.0001914179,0.0012959323,0.000030319768],"about_ca_topic_score_codex":0.002013494,"about_ca_topic_score_gemma":0.0040069483,"teacher_disagreement_score":0.008492162,"about_ca_system_score_codex":0.0006956139,"about_ca_system_score_gemma":0.0009560565,"threshold_uncertainty_score":0.04440832},"labels":[],"label_agreement":null},{"id":"W2790826021","doi":"10.2147/ott.s155160","title":"Prognostic significance of epidermal growth factor receptor expression in glioma patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Science and Technology of Sichuan Province","keywords":"Epidermal growth factor receptor; Glioma; Epidermal growth factor; Expression (computer science); Medicine; Oncology; Cancer research; Factor (programming language); Internal medicine; Receptor; Computer science","score_opus":0.01804743681803861,"score_gpt":0.2716772698489575,"score_spread":0.2536298330309189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790826021","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02563232,0.97204846,0.0006557219,0.00040078087,0.00018177892,0.0000717456,0.0005960347,0.000020812702,0.00039245264],"genre_scores_gemma":[0.6892724,0.306363,0.0016058518,0.0007850655,0.00043364926,0.00022439272,0.00095305947,0.00002667324,0.00033581283],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9938492,0.002841704,0.0014928499,0.0008404492,0.0007579832,0.0002178327],"domain_scores_gemma":[0.98932844,0.0076247966,0.0019521089,0.0004512879,0.00052888476,0.000114523216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009458043,0.0014623844,0.006521381,0.0041135806,0.0003608566,0.0019085612,0.001077125,0.0014202049,0.0013585822],"category_scores_gemma":[0.019266523,0.0006815357,0.021623755,0.004866819,0.00044124937,0.0008873102,0.00068631663,0.0010562158,0.00013895071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004582345,0.00004331841,0.07709783,0.11175011,0.77875286,0.00019163846,0.00009722339,0.0017982248,0.0007314041,0.00020285946,0.0007379776,0.024014207],"study_design_scores_gemma":[0.00046726174,0.00043559066,0.04505284,0.008511084,0.941362,0.00031196862,0.000058733724,0.0006534081,0.0005261314,0.0004493083,0.002137818,0.0000337816],"about_ca_topic_score_codex":0.003449174,"about_ca_topic_score_gemma":0.004361183,"teacher_disagreement_score":0.009458043,"about_ca_system_score_codex":0.0011244435,"about_ca_system_score_gemma":0.0011636313,"threshold_uncertainty_score":0.050019562},"labels":[],"label_agreement":null},{"id":"W2793187279","doi":"10.2147/ott.s148363","title":"Response to crizotinib in a non-small-cell lung cancer patient harboring an <em>EML4-ALK</em> fusion with an atypical <em>LTBP1</em> insertion","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Lung cancer; Fusion gene; Cancer research; KRAS; Medicine; Cancer; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.01388789291140281,"score_gpt":0.2961615911127861,"score_spread":0.2822736982013833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793187279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933769,0.0025588868,0.00021405534,0.0010148858,0.00007109479,0.000062543724,0.00019322489,0.000036361464,0.0024720985],"genre_scores_gemma":[0.9986297,0.00031120048,0.00014252757,0.00023699824,0.0000355484,0.000007995732,0.0001919512,0.0000043489204,0.00043958938],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99985254,0.000022659882,0.000018097106,0.000035194178,0.000024156954,0.000047308793],"domain_scores_gemma":[0.9997824,0.000052798896,0.000021199761,0.000008364593,0.000020950698,0.00011426564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017104771,0.00045200853,0.00070481864,0.00031678492,0.0004501993,0.00030437525,0.00033288437,0.0006724611,0.0008097872],"category_scores_gemma":[0.00051788223,0.00013719652,0.00038478532,0.00023578372,0.00018976897,0.00017185004,0.00014213852,0.00101842,0.00029857238],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023027094,0.001574308,0.26833385,0.0005285821,0.00062361447,0.48285994,0.00075192365,0.003969903,0.114510216,0.00026447044,0.0046959026,0.0988601],"study_design_scores_gemma":[0.0019741645,0.016857445,0.5923695,0.00010181961,0.0010580041,0.33679408,0.0005471564,0.010795691,0.027525218,0.00038102642,0.011470837,0.00012508545],"about_ca_topic_score_codex":0.0028266083,"about_ca_topic_score_gemma":0.0066093225,"teacher_disagreement_score":0.0028266083,"about_ca_system_score_codex":0.0010423344,"about_ca_system_score_gemma":0.0003148195,"threshold_uncertainty_score":0.007562697},"labels":[],"label_agreement":null},{"id":"W2794323096","doi":"10.2147/ott.s158171","title":"Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Science and Technology Department of Zhejiang Province; Department of Education of Zhejiang Province","keywords":"Medicine; Meta-analysis; Neuroendocrine tumors; Systematic review; Randomized controlled trial; Primary tumor; Internal medicine; Odds ratio; MEDLINE; Oncology; Surgery; Cancer; Metastasis","score_opus":0.04080444151786777,"score_gpt":0.33365198101943877,"score_spread":0.292847539501571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794323096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033704732,0.995323,0.00033194738,0.00019119284,0.00012056392,0.00017507217,0.00030986225,0.00001319101,0.00016460914],"genre_scores_gemma":[0.14952572,0.8459689,0.0016611172,0.0009015598,0.00027158402,0.00080851413,0.0006350565,0.000022851473,0.00020482668],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99217075,0.0037272049,0.0022822798,0.00075814524,0.00082520186,0.00023642958],"domain_scores_gemma":[0.9813456,0.01369633,0.0028389671,0.00047316164,0.0014066276,0.00023931227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012792849,0.0026693386,0.016442137,0.005790438,0.00051216024,0.0028702563,0.0019688096,0.0022353448,0.0028961543],"category_scores_gemma":[0.032508124,0.0013519028,0.038396463,0.0056819483,0.0006478766,0.0016668554,0.0012394678,0.001558332,0.00024602492],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013732268,0.000024933028,0.0036797023,0.45568952,0.52771354,0.00012742374,0.000081381586,0.00051192316,0.00017748424,0.00011700054,0.00048291296,0.010021068],"study_design_scores_gemma":[0.0003621227,0.00017256534,0.0029549818,0.033811055,0.9608604,0.000098336866,0.0000461588,0.00016335526,0.00008672547,0.00015400638,0.0012683742,0.000021911517],"about_ca_topic_score_codex":0.0061731944,"about_ca_topic_score_gemma":0.013302804,"teacher_disagreement_score":0.016442137,"about_ca_system_score_codex":0.0023601141,"about_ca_system_score_gemma":0.003686798,"threshold_uncertainty_score":0.06765592},"labels":[],"label_agreement":null},{"id":"W2796235852","doi":"10.2147/ott.s152140","title":"Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysis","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Publication bias; Meta-analysis; Odds ratio; Funnel plot; WWOX; Medicine; Internal medicine; Oncology; Case-control study; Genetic model; Cancer; Genetics; Gene; Biology; Suppressor","score_opus":0.023198661660829182,"score_gpt":0.25517973883306566,"score_spread":0.23198107717223648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796235852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020561853,0.97602046,0.0013814465,0.0004970767,0.0002728268,0.00015759689,0.0006039938,0.000034016735,0.00047075032],"genre_scores_gemma":[0.45556444,0.53629875,0.0034151531,0.0015456504,0.0007581066,0.0005354934,0.0013485047,0.000056954104,0.00047695887],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99281526,0.003170126,0.0018970945,0.0011146563,0.00076365395,0.00023926374],"domain_scores_gemma":[0.9795024,0.015801612,0.0025521936,0.0008146681,0.0010513061,0.00027781306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013786195,0.002817985,0.010439134,0.0046103117,0.0007327896,0.0028084405,0.0019513143,0.0019568568,0.0032099108],"category_scores_gemma":[0.027502889,0.0012073715,0.035547283,0.00580699,0.00068477803,0.0014898324,0.0011828785,0.0019754488,0.0002567855],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035161255,0.00004791939,0.032554798,0.080093004,0.8685055,0.0002768342,0.00010347924,0.0006795977,0.00034789843,0.00015883871,0.0005657865,0.013150264],"study_design_scores_gemma":[0.00035616156,0.00016065726,0.012307758,0.0048986794,0.9803837,0.00013034999,0.000040567636,0.00031176527,0.000103527804,0.0002831849,0.0010045288,0.00001917996],"about_ca_topic_score_codex":0.0048257792,"about_ca_topic_score_gemma":0.008544501,"teacher_disagreement_score":0.013786195,"about_ca_system_score_codex":0.0011684485,"about_ca_system_score_gemma":0.0017319485,"threshold_uncertainty_score":0.072909236},"labels":[],"label_agreement":null},{"id":"W2801288479","doi":"10.2147/ott.s151751","title":"Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Capital Foundation of Medical Development","keywords":"Hepatocellular carcinoma; Medicine; Meta-analysis; Internal medicine; Cirrhosis; Hazard ratio; Oncology; Confidence interval; Odds ratio; Cochrane Library; Biomarker; Stage (stratigraphy); Gastroenterology; Biology","score_opus":0.020521972521979383,"score_gpt":0.2598492306203965,"score_spread":0.23932725809841712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801288479","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05588506,0.9404186,0.0012309105,0.00041318513,0.00026927938,0.000111616544,0.0012226742,0.000050482635,0.00039820714],"genre_scores_gemma":[0.81414557,0.1806712,0.001828517,0.00061516697,0.00037724912,0.00042105853,0.0014895491,0.000046756493,0.00040502613],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99584216,0.0018514296,0.00085204025,0.0007991478,0.00041421063,0.0002410456],"domain_scores_gemma":[0.9921461,0.0053913575,0.0012158692,0.00046154097,0.0005909863,0.00019414604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00748938,0.0017779439,0.009431816,0.0036468394,0.00061783096,0.001796533,0.0013323454,0.0015308573,0.0019336333],"category_scores_gemma":[0.011254447,0.0010093042,0.028811585,0.00539316,0.0004077717,0.0009236285,0.0010259872,0.0012730355,0.00019920098],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058133486,0.000045358138,0.06704137,0.0573765,0.85692304,0.00027733654,0.00006378479,0.0013989377,0.000679005,0.000113712806,0.00078190607,0.009485723],"study_design_scores_gemma":[0.00039067672,0.00025457217,0.03161805,0.0025240732,0.9628418,0.00017321385,0.000035271496,0.00078231376,0.00022271172,0.00016862915,0.0009625075,0.000026195883],"about_ca_topic_score_codex":0.0047726664,"about_ca_topic_score_gemma":0.0070104944,"teacher_disagreement_score":0.009431816,"about_ca_system_score_codex":0.0011787786,"about_ca_system_score_gemma":0.0012772493,"threshold_uncertainty_score":0.03960812},"labels":[],"label_agreement":null},{"id":"W2804093461","doi":"10.2147/ott.s165209","title":"A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Jilin University","keywords":"Axilla; Aggressive fibromatosis; Fibromatosis; Pathological; Medicine; Radiology; Positron emission tomography; Computed tomography; Pathology; Internal medicine","score_opus":0.01284677504363748,"score_gpt":0.2984318396175701,"score_spread":0.2855850645739326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804093461","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3206378,0.6463008,0.0051057013,0.004023081,0.0022968953,0.00022845903,0.0005016122,0.00040153664,0.020504175],"genre_scores_gemma":[0.7383068,0.24498469,0.002990362,0.0021993774,0.0070211138,0.00006893316,0.00033657954,0.0000569096,0.00403523],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996062,0.00003789018,0.0001078871,0.000102871614,0.00007265072,0.00007257171],"domain_scores_gemma":[0.99918467,0.00026011062,0.0002806398,0.00006188312,0.00007196012,0.0001407377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000297848,0.0013862349,0.0010746513,0.005054547,0.0010819543,0.0015617254,0.0011454866,0.00250744,0.0031998542],"category_scores_gemma":[0.0010662092,0.00058570906,0.0005515484,0.003644863,0.0013059033,0.002199346,0.0009007217,0.001031138,0.0012227917],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003319349,0.00006415853,0.008205004,0.0011619903,0.00005728772,0.9681149,0.00026375684,0.0001243958,0.0022540048,0.00031223986,0.0027654534,0.016643671],"study_design_scores_gemma":[0.000004990596,0.000022265805,0.0033428858,0.00015676451,0.000051395145,0.9901972,0.00020715265,0.00008852238,0.0002597739,0.00018278247,0.005471919,0.000014411065],"about_ca_topic_score_codex":0.0007358431,"about_ca_topic_score_gemma":0.0011772867,"teacher_disagreement_score":0.005054547,"about_ca_system_score_codex":0.000477316,"about_ca_system_score_gemma":0.00047037515,"threshold_uncertainty_score":0.010704577},"labels":[],"label_agreement":null},{"id":"W2883816907","doi":"10.2147/ott.s166399","title":"Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Emergency Physicians","funders":"","keywords":"Eribulin; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Radiomics; Cancer; Radiology","score_opus":0.04725875636328954,"score_gpt":0.3979276726502522,"score_spread":0.3506689162869627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883816907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957491,0.0031809239,0.00017318357,0.00008451351,0.000012152879,0.000013939538,0.00013085353,0.000004442581,0.00065094046],"genre_scores_gemma":[0.99847454,0.00075902825,0.00009162786,0.000088619505,0.000021909027,0.000016287666,0.0003488877,0.0000018161462,0.00019727812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985707,0.00004891295,0.000016306376,0.000018041905,0.000031892614,0.000027690796],"domain_scores_gemma":[0.99925786,0.00012069394,0.00040261023,0.000018333358,0.00006018653,0.00014029145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030596583,0.00013291108,0.0002561959,0.00012557677,0.00019330549,0.00030959025,0.000096298274,0.00013830564,0.0005911382],"category_scores_gemma":[0.0008307307,0.000040750812,0.0002876719,0.00019862724,0.00011755422,0.00017393759,0.00016540418,0.00032456053,0.00007676509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017713688,0.0008380497,0.82696456,0.0007869535,0.00039949457,0.0033950205,0.00043239535,0.0013024918,0.014315643,0.00019231476,0.001706544,0.13195288],"study_design_scores_gemma":[0.000997316,0.042286087,0.9096246,0.00025750764,0.00074543926,0.020617032,0.00063435134,0.0029213978,0.008346435,0.00031163642,0.013223987,0.000034283174],"about_ca_topic_score_codex":0.00037280293,"about_ca_topic_score_gemma":0.0006392746,"teacher_disagreement_score":0.0005911382,"about_ca_system_score_codex":0.00032092826,"about_ca_system_score_gemma":0.00025298336,"threshold_uncertainty_score":0.002328515},"labels":[],"label_agreement":null},{"id":"W2888206604","doi":"10.2147/ott.s167355","title":"Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Meta-analysis; Cancer; Biomarker; Biology","score_opus":0.04808960426515019,"score_gpt":0.3356476239631523,"score_spread":0.2875580196980021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888206604","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10115712,0.8918534,0.0023057421,0.0004755192,0.00029840894,0.00018623748,0.0029690943,0.00008024486,0.00067425985],"genre_scores_gemma":[0.8687141,0.12506369,0.0020129469,0.00053321605,0.00034939795,0.00043759926,0.0024005962,0.00005504027,0.0004334321],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950119,0.0020734116,0.0010749556,0.0010379271,0.0005195417,0.00028222948],"domain_scores_gemma":[0.98847777,0.008115864,0.0016392912,0.0007601672,0.00072834553,0.00027846757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075309398,0.0020334087,0.010272227,0.0046734707,0.0006803854,0.0020977836,0.0016470843,0.0016927989,0.0023493986],"category_scores_gemma":[0.010880897,0.0011271016,0.034764085,0.0070065353,0.00047178852,0.0011136348,0.0010849109,0.0016118375,0.00024536642],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048800115,0.00003986318,0.09264431,0.03678015,0.8562144,0.00028885715,0.00006222993,0.001357529,0.00061873073,0.00008537738,0.00058407587,0.006444546],"study_design_scores_gemma":[0.0004256519,0.00025729247,0.037866343,0.0017350548,0.95740056,0.0001987694,0.000041161296,0.0008274677,0.00017960847,0.00018128476,0.00086020835,0.000026664102],"about_ca_topic_score_codex":0.0037552444,"about_ca_topic_score_gemma":0.006245063,"teacher_disagreement_score":0.010272227,"about_ca_system_score_codex":0.0010119366,"about_ca_system_score_gemma":0.0011623722,"threshold_uncertainty_score":0.039827883},"labels":[],"label_agreement":null},{"id":"W2891165291","doi":"10.2147/ott.s155438","title":"Evaluation of supportive and barrier-protective skin care products in the daily prevention and treatment of cutaneous toxicity during systemic chemotherapy","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal General Hospital; Montreal Children's Hospital","funders":"","keywords":"Medicine; Erythema; Tolerability; Casual; Dermatology; Summary of Product Characteristics; Skin care; Discontinuation; Skin cancer; Observational study; Adverse effect; Desquamation; Internal medicine; Cancer; Pharmacology; Drug; Nursing","score_opus":0.020584876058098344,"score_gpt":0.29389508986183394,"score_spread":0.2733102138037356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891165291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981014,0.0015040856,0.00007442434,0.000015675514,0.000004818166,0.000055505778,0.000037857142,0.0000031578966,0.00020309967],"genre_scores_gemma":[0.9991478,0.00039234123,0.0002754581,0.000027165435,0.000015406955,0.0000343215,0.000055989294,7.3085386e-7,0.00005081729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990074,0.0005278829,0.000112249014,0.0000887602,0.00021374092,0.000049933096],"domain_scores_gemma":[0.9973007,0.0007849161,0.0013887228,0.00008284258,0.00020263021,0.00024029544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016121698,0.00020181228,0.00053145824,0.00023535988,0.00018224998,0.00028536035,0.00018452416,0.00029238214,0.0008090451],"category_scores_gemma":[0.002904827,0.00009838503,0.0004165711,0.00026657444,0.00015736872,0.00024241535,0.00012944,0.0003074164,0.00008467431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050301958,0.008779546,0.7415954,0.0016848556,0.00071586284,0.00029680502,0.00045734394,0.00046895034,0.015393294,0.000040951654,0.0003119994,0.17995307],"study_design_scores_gemma":[0.0027092383,0.19452147,0.78847635,0.00015074639,0.00086373073,0.0013781951,0.00022677546,0.0008827942,0.008859945,0.000041155567,0.0018682533,0.00002134455],"about_ca_topic_score_codex":0.00014852374,"about_ca_topic_score_gemma":0.00018327778,"teacher_disagreement_score":0.0016121698,"about_ca_system_score_codex":0.00016245223,"about_ca_system_score_gemma":0.0002078086,"threshold_uncertainty_score":0.008526087},"labels":[],"label_agreement":null},{"id":"W2896789425","doi":"10.2147/ott.s167872","title":"Down-regulation of CXCL 11 inhibits colorectal cancer cell growth and epithelial-mesenchymal transition","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Epithelial–mesenchymal transition; Colorectal cancer; Mesenchymal stem cell; Transition (genetics); Cancer research; Cell growth; Medicine; Oncology; Cancer; Chemistry; Internal medicine; Pathology; Metastasis; Gene; Biochemistry","score_opus":0.009312997384674244,"score_gpt":0.24903343032281497,"score_spread":0.23972043293814072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896789425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910513,0.0035709993,0.0019649807,0.00029835192,0.00012253589,0.00005101285,0.0003308709,0.00017453141,0.00243539],"genre_scores_gemma":[0.9927918,0.002281703,0.0014739301,0.00008387719,0.000020046324,0.000056545767,0.00048395526,0.000013710437,0.0027945163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999082,0.000015667421,0.000010011327,0.00001018896,0.000024719924,0.00003118187],"domain_scores_gemma":[0.999946,0.0000119483,0.000012508617,0.000005954592,0.000008639382,0.000015052213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096191165,0.00026760553,0.00023106474,0.00019064423,0.00011523152,0.00017797374,0.000118291304,0.00013234817,0.0017108032],"category_scores_gemma":[0.00010146154,0.000057076722,0.00017896653,0.00014918232,0.00019619463,0.00011700545,0.00012041609,0.00064524234,0.0003069677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056551537,0.00039596623,0.0006461478,0.00024172656,0.000012637864,0.00006538046,0.000026046262,0.00035750843,0.9854069,0.00025514694,0.0006746696,0.011352372],"study_design_scores_gemma":[0.00008675389,0.0022112867,0.0047316337,0.000016817206,0.000038748745,0.00024048187,0.000044161647,0.0022033725,0.98149556,0.0000636611,0.008859489,0.0000079950505],"about_ca_topic_score_codex":0.00051706244,"about_ca_topic_score_gemma":0.0010337589,"teacher_disagreement_score":0.0017108032,"about_ca_system_score_codex":0.00023859904,"about_ca_system_score_gemma":0.00039069395,"threshold_uncertainty_score":0.0057231784},"labels":[],"label_agreement":null},{"id":"W2897385169","doi":"10.2147/ott.s184898","title":"Novel EXO-T vaccine using polyclonal CD4<sup>+</sup> T cells armed with HER2-specific exosomes for HER2-positive breast cancer","year":2018,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Microvesicles; Polyclonal antibodies; Breast cancer; Medicine; Trastuzumab; Cancer research; Virology; Cancer; Immunology; Antibody; Chemistry; Internal medicine; microRNA; Biochemistry","score_opus":0.05716456505432307,"score_gpt":0.35005826712262816,"score_spread":0.2928937020683051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897385169","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009975706,0.9956922,0.0005311208,0.0004806429,0.00045094537,0.000016532375,0.000029758532,0.000014453855,0.0017868952],"genre_scores_gemma":[0.0053163823,0.9911164,0.0006156132,0.0004199803,0.00018777703,0.000031362586,0.000057428293,0.0000033314898,0.002251812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992645,0.000012010088,0.000010068086,0.000016513935,0.0000257683,0.000009224161],"domain_scores_gemma":[0.9999386,0.00002369058,0.000010564763,0.0000021531746,0.00001825833,0.000006732153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024903656,0.00047975843,0.00049476454,0.001065809,0.00015093785,0.00046493218,0.00037333532,0.0007860943,0.0016065716],"category_scores_gemma":[0.00024082972,0.00014550085,0.0003175206,0.00083949196,0.00022995772,0.00072807714,0.0003187985,0.0010709419,0.0008356957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013472165,0.000162472,0.00021082968,0.013168765,0.000079275844,0.00033167624,0.000059870057,0.00046518148,0.012099508,0.006285447,0.025622103,0.9413802],"study_design_scores_gemma":[0.000035732413,0.00033345885,0.00062627945,0.0016177727,0.00009172306,0.0019368686,0.000048792932,0.00028171463,0.0059812604,0.0012151018,0.9878088,0.000022572156],"about_ca_topic_score_codex":0.00039043726,"about_ca_topic_score_gemma":0.00060535525,"teacher_disagreement_score":0.0016065716,"about_ca_system_score_codex":0.0003475901,"about_ca_system_score_gemma":0.00048507878,"threshold_uncertainty_score":0.005374551},"labels":[],"label_agreement":null},{"id":"W2900767667","doi":"10.2147/ott.s168478","title":"Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population","year":2018,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Deanship of Scientific Research, King Saud University; King Saud University","keywords":"Colorectal cancer; Toll-like receptor; Toll; Medicine; Oncology; Cancer research; Receptor; Internal medicine; Traditional medicine; Genetics; Cancer; Bioinformatics; Immunology; Biology; Innate immune system","score_opus":0.007153032326777952,"score_gpt":0.2460535840700643,"score_spread":0.23890055174328637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900767667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992113,0.00041696918,0.00006205378,0.00005647379,0.000004297277,0.0000020074522,0.00010833731,0.0000014870251,0.00013706279],"genre_scores_gemma":[0.99959844,0.00013979107,0.00007163324,0.000019942227,0.000004869792,0.000001970789,0.000084722014,7.723942e-7,0.00007789788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997881,0.00007093941,0.000022988606,0.000053510503,0.000032424978,0.00003200656],"domain_scores_gemma":[0.999483,0.000099211626,0.00025787193,0.000029870633,0.00006969374,0.000060329407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040508405,0.00023269615,0.00016572498,0.0005455207,0.00023223115,0.00031228786,0.00019637223,0.0003004181,0.0016411532],"category_scores_gemma":[0.0008435707,0.00015409866,0.00025801774,0.00053253403,0.00017563936,0.00015179416,0.00021381558,0.00020250116,0.00011978805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029823155,0.000018393017,0.9946037,0.000029612736,0.00008100386,0.00019169581,0.00015958193,0.00007939166,0.0020682537,0.000046613903,0.00008145713,0.0023421461],"study_design_scores_gemma":[0.000010688089,0.000090594476,0.9980603,0.000014336903,0.00005363697,0.0005142507,0.00021829094,0.00040787173,0.00024892783,0.000050628496,0.0003256542,0.000004803223],"about_ca_topic_score_codex":0.00484661,"about_ca_topic_score_gemma":0.0031474943,"teacher_disagreement_score":0.00484661,"about_ca_system_score_codex":0.00020682006,"about_ca_system_score_gemma":0.00017544135,"threshold_uncertainty_score":0.00963676},"labels":[],"label_agreement":null},{"id":"W2913788535","doi":"10.2147/ott.s191478","title":"<p>Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastoma</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"National Cancer Institute","keywords":"Neuroblastoma; Flow cytometry; In vitro; In vivo; Cancer research; Medicine; Cell culture; Cytotoxicity; Cytotoxic T cell; In vitro toxicology; Cancer; Pharmacology; Immunology; Biology; Internal medicine","score_opus":0.018726239825966873,"score_gpt":0.2721011470440515,"score_spread":0.2533749072180846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913788535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184763,0.002193289,0.0014631028,0.00012600458,0.00006510646,0.0000762185,0.00055831077,0.00014119975,0.0035291996],"genre_scores_gemma":[0.9914766,0.0015665145,0.002539205,0.00005913097,0.000015258617,0.00006857232,0.0010108299,0.000022407783,0.0032414033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999912,0.000018225173,0.000007712132,0.000016816612,0.000024165165,0.000020926715],"domain_scores_gemma":[0.9999244,0.000016766695,0.000017069679,0.000011086147,0.000008531945,0.00002211495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018550729,0.00036976265,0.0003034967,0.00022498434,0.000095020405,0.00016959953,0.00033143308,0.00020458024,0.0009484812],"category_scores_gemma":[0.000089421024,0.00011263025,0.00018754315,0.00015251669,0.0002007837,0.0001865816,0.00010668045,0.0005905528,0.00034627723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046482947,0.00042039205,0.00030698604,0.00014710233,0.000016742775,0.00022999494,0.000031674608,0.00088926114,0.98938864,0.00011959356,0.00047251527,0.0075122304],"study_design_scores_gemma":[0.00023935789,0.0074261012,0.004143776,0.000022046002,0.000045904366,0.0007556905,0.000023141589,0.002817324,0.9802081,0.000044474054,0.004264455,0.000009663294],"about_ca_topic_score_codex":0.0019202335,"about_ca_topic_score_gemma":0.00340839,"teacher_disagreement_score":0.0019202335,"about_ca_system_score_codex":0.00031204408,"about_ca_system_score_gemma":0.00038742644,"threshold_uncertainty_score":0.0038180947},"labels":[],"label_agreement":null},{"id":"W2936758797","doi":"10.2147/ott.s191179","title":"<p>Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis</p>","year":2019,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fourth Military Medical University","keywords":"Medicine; Rituximab; Waldenstrom macroglobulinemia; Macroglobulinemia; Meta-analysis; Internal medicine; Oncology; Lymphoma; Multiple myeloma","score_opus":0.0625034392856693,"score_gpt":0.34469866020691664,"score_spread":0.2821952209212473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936758797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039121616,0.9950682,0.00023279109,0.00016928937,0.0000871683,0.00015083495,0.00018194811,0.000015168309,0.000182336],"genre_scores_gemma":[0.14717302,0.848235,0.0018843948,0.0008261281,0.00030673004,0.0008075363,0.0004879579,0.00002076339,0.0002584927],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99430025,0.0029672245,0.0013853279,0.0005031003,0.00063191284,0.00021218268],"domain_scores_gemma":[0.98888725,0.00790616,0.0020887605,0.00023931626,0.00070898613,0.0001695452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010478723,0.0024970758,0.015065049,0.005658746,0.00050452584,0.0029068706,0.0019556761,0.0021860152,0.0027207187],"category_scores_gemma":[0.018606596,0.001211891,0.03198921,0.005536015,0.0005482971,0.0015763043,0.001077421,0.0015706351,0.00023827779],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034388613,0.000053183245,0.0031234033,0.38535687,0.5833868,0.00012268146,0.000086561944,0.0006442748,0.00030586345,0.00012799114,0.00076888787,0.022584656],"study_design_scores_gemma":[0.0007617872,0.0003148208,0.0026913725,0.024373699,0.9696689,0.00009096521,0.000035922494,0.00022359616,0.00011917532,0.00013763514,0.0015618864,0.000020132637],"about_ca_topic_score_codex":0.0044519794,"about_ca_topic_score_gemma":0.010830972,"teacher_disagreement_score":0.015065049,"about_ca_system_score_codex":0.002312161,"about_ca_system_score_gemma":0.0027371333,"threshold_uncertainty_score":0.05541742},"labels":[],"label_agreement":null},{"id":"W2952542100","doi":"10.2147/ott.s196322","title":"<p>The role of miR-382-5p in glioma cell proliferation, migration and invasion</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Nurses in Oncology","funders":"","keywords":"Glioma; Cancer research; Cell growth; Cell migration; Cell; Medicine; Biology; Cell biology; Genetics","score_opus":0.004721691462164456,"score_gpt":0.20947164118004732,"score_spread":0.20474994971788288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952542100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4859758,0.02812015,0.32163092,0.0073091313,0.0024688994,0.0023700835,0.03165394,0.01849092,0.101980135],"genre_scores_gemma":[0.6566243,0.011978829,0.18130405,0.0013648657,0.00025681584,0.0026346212,0.020258788,0.0021173996,0.123460285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993563,0.000060523733,0.000057050307,0.000156282,0.0002827128,0.00008708828],"domain_scores_gemma":[0.9997249,0.000035362504,0.00006697262,0.000041942505,0.000074246054,0.000056533754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059420493,0.0011621618,0.00056693546,0.00090944546,0.0006388906,0.0006756828,0.00074311276,0.0006699382,0.0116265975],"category_scores_gemma":[0.00043008043,0.000548969,0.0005690611,0.00068867434,0.0007283571,0.000819718,0.00044574327,0.0013563385,0.0065191723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034560577,0.000091909096,0.00037306364,0.00048562727,0.000024305506,0.00041751252,0.00007999675,0.00027803102,0.9612713,0.0018164729,0.005677677,0.029138556],"study_design_scores_gemma":[0.000056268218,0.00028595258,0.0026198304,0.000037140475,0.000041104646,0.00086275797,0.000043072123,0.0024149593,0.940258,0.0005376255,0.052825905,0.000017312725],"about_ca_topic_score_codex":0.0019534307,"about_ca_topic_score_gemma":0.002529572,"teacher_disagreement_score":0.0116265975,"about_ca_system_score_codex":0.0010723579,"about_ca_system_score_gemma":0.0010589861,"threshold_uncertainty_score":0.038894832},"labels":[],"label_agreement":null},{"id":"W2987649946","doi":"10.2147/ott.s229514","title":"<p>Emerging Roles Of hsa-circ-0046600 Targeting The miR-640/HIF-1α Signalling Pathway In The Progression Of HCC</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Henan Provincial People's Hospital","keywords":"Hepatocellular carcinoma; Western blot; Cancer research; microRNA; Molecular biology; Biomarker; Real-time polymerase chain reaction; Chemistry; Biology; Gene; Biochemistry","score_opus":0.007634631463003093,"score_gpt":0.2515867747354772,"score_spread":0.2439521432724741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987649946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85519636,0.08448408,0.02248517,0.004745912,0.00076766394,0.00021487863,0.0022868009,0.0015419355,0.028277244],"genre_scores_gemma":[0.95676094,0.022103151,0.0065365587,0.0012976002,0.0002606988,0.0000903853,0.0017230113,0.00013168101,0.011095931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99990237,0.000011149774,0.000007456748,0.000024382323,0.000037853362,0.000016672459],"domain_scores_gemma":[0.9998723,0.000012960986,0.000042588643,0.000010642492,0.000025889056,0.000035691133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030655097,0.00031141998,0.00025606574,0.00022888563,0.0001831073,0.000552986,0.00022106075,0.0004103649,0.0027811183],"category_scores_gemma":[0.00019445237,0.00016138199,0.0002782232,0.00023450579,0.0004181869,0.000289103,0.00022411892,0.00063507893,0.0010182506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009985447,0.00009582678,0.005722518,0.00091453694,0.000048024947,0.0012152629,0.00012684663,0.00047137894,0.90422684,0.0018835765,0.004352302,0.0799443],"study_design_scores_gemma":[0.00024505117,0.0018019166,0.06967555,0.00015874092,0.00026495467,0.00913758,0.00027021675,0.009733854,0.7940375,0.003121558,0.11149847,0.000054583903],"about_ca_topic_score_codex":0.00041129882,"about_ca_topic_score_gemma":0.00030509316,"teacher_disagreement_score":0.0027811183,"about_ca_system_score_codex":0.0002732883,"about_ca_system_score_gemma":0.00038125648,"threshold_uncertainty_score":0.009303808},"labels":[],"label_agreement":null},{"id":"W2995767122","doi":"10.2147/ott.s235811","title":"<p>Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection</p>","year":2019,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada; Queen's University; Russian Foundation for Basic Research","keywords":"Fucosylation; Prostate; Medicine; Breast tumor; Peptide; Spheroid; Internal medicine; Chemistry; Biochemistry; Glycoprotein; Breast cancer; Cancer","score_opus":0.005540476564820925,"score_gpt":0.25823770620068376,"score_spread":0.25269722963586283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995767122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879853,0.00030155343,0.008570128,0.00011365036,0.000041550826,0.000037534606,0.00022752117,0.00040376675,0.0023189161],"genre_scores_gemma":[0.9777469,0.00046782053,0.01716179,0.000066474124,0.00000827741,0.00006989946,0.00047962146,0.000111445785,0.0038877653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999502,0.000004956174,0.0000042879756,0.000013703737,0.000015267053,0.000011635757],"domain_scores_gemma":[0.99993956,0.000012927983,0.000021550306,0.000006165652,0.0000077327895,0.000012015733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009748952,0.00022753181,0.00010209403,0.000094272116,0.00006699916,0.00012451864,0.00015491676,0.00013092875,0.0013155763],"category_scores_gemma":[0.00010080075,0.000088476976,0.00014347504,0.0000813997,0.000117178504,0.00014487826,0.00011638663,0.0002353848,0.00025202447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007224264,0.00002288071,0.00008013839,0.00002352048,0.0000021816325,0.00003277307,0.000007808951,0.00014956495,0.9966664,0.00004596298,0.00009597852,0.002800568],"study_design_scores_gemma":[0.0000034039538,0.000079013334,0.00051251106,8.775195e-7,0.0000016959162,0.00003665676,0.0000026315909,0.0017331975,0.99727756,0.0000068002473,0.0003439424,0.0000017445202],"about_ca_topic_score_codex":0.00071966153,"about_ca_topic_score_gemma":0.0006858406,"teacher_disagreement_score":0.0013155763,"about_ca_system_score_codex":0.00016345565,"about_ca_system_score_gemma":0.00011388692,"threshold_uncertainty_score":0.004401028},"labels":[],"label_agreement":null},{"id":"W3107430348","doi":"10.2147/ott.s281397","title":"<p>The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma Cells</p>","year":2020,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kane Biotech (Canada)","funders":"","keywords":"Jurkat cells; Monoclonal antibody; Cancer research; Molecular biology; Cell culture; Antibody; Chemistry; Immunology; Cell biology; Medicine; Biology; T cell; Immune system; Genetics","score_opus":0.012559176557217866,"score_gpt":0.2609022516389771,"score_spread":0.24834307508175926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107430348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958486,0.0019644846,0.005276152,0.00012806836,0.00005966192,0.00004845089,0.00022004427,0.00012571544,0.0025924179],"genre_scores_gemma":[0.98797745,0.001193082,0.006344271,0.00007431077,0.000028568867,0.00008390669,0.00052466174,0.000015730217,0.0037580568],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985075,0.0000288224,0.000015335574,0.00003585976,0.00002950689,0.000039636394],"domain_scores_gemma":[0.9999435,0.000012408841,0.000013424375,0.000007579255,0.000010087046,0.000012878063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001510922,0.0004471315,0.00020283335,0.00025579223,0.00013477617,0.00014300738,0.00016302512,0.00020039562,0.0012511887],"category_scores_gemma":[0.000054355776,0.00011802945,0.00028592627,0.00014608195,0.00015698773,0.00016993444,0.00010782066,0.00046403098,0.00036971402],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009628076,0.00003942118,0.00015105141,0.000041173647,0.0000050406106,0.00003494592,0.000007445633,0.000032929904,0.99823296,0.000049501003,0.000051826217,0.0012574821],"study_design_scores_gemma":[0.000018293264,0.00036707768,0.0016267917,0.000003491414,0.000015931615,0.00014355707,0.000007239871,0.0006294935,0.9962096,0.000013263007,0.0009631819,0.000002124509],"about_ca_topic_score_codex":0.00047670715,"about_ca_topic_score_gemma":0.00059385557,"teacher_disagreement_score":0.0012511887,"about_ca_system_score_codex":0.00025580465,"about_ca_system_score_gemma":0.00020223045,"threshold_uncertainty_score":0.0041856766},"labels":[],"label_agreement":null},{"id":"W3115177595","doi":"10.2147/ott.s273803","title":"The Roles of Integrin α5β1 in Human Cancer","year":2020,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Agriculture","funders":"Fundamental Research Funds for the Central Universities; Natural Science Foundation of Chongqing; National Natural Science Foundation of China","keywords":"Integrin; Fibronectin; Extracellular matrix; Cell adhesion; Cell biology; Metastasis; Cancer research; Angiogenesis; Cancer cell; Carcinogenesis; Cell; Biology; Motility; Collagen receptor; Mediator; Cell migration; Tumor progression; Cancer; Biochemistry; Genetics","score_opus":0.06734611580005802,"score_gpt":0.42024098109027386,"score_spread":0.35289486529021585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115177595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010921871,0.9982981,0.000083127255,0.0002297315,0.00017958073,0.000003185569,0.0000118977405,0.0000049126365,0.0010802341],"genre_scores_gemma":[0.00072095107,0.99838424,0.00009211071,0.00014457852,0.00010739583,0.0000036978402,0.000019957606,7.6968564e-7,0.0005263011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998165,0.000031091386,0.000026699565,0.00003099538,0.00007575659,0.000018962857],"domain_scores_gemma":[0.9998599,0.000052931253,0.000020378346,0.0000046985433,0.000047473794,0.000014562468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044025504,0.00065582036,0.00075182883,0.0015859893,0.00022618838,0.00069144566,0.00049354666,0.0007567728,0.0022285401],"category_scores_gemma":[0.00043978632,0.00019512749,0.00038265085,0.0017493764,0.00037951532,0.00076666416,0.00044178157,0.0013546242,0.0015307661],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005170949,0.000029858937,0.00021957562,0.0111046955,0.000060364928,0.0001958194,0.00007579269,0.00028117836,0.0025958142,0.0045196116,0.028572325,0.9522931],"study_design_scores_gemma":[0.0000075397534,0.00006493079,0.0007031628,0.0018235533,0.000068692905,0.0010336214,0.000037715272,0.00005035885,0.0004868008,0.0013844935,0.994327,0.000012116534],"about_ca_topic_score_codex":0.0013909056,"about_ca_topic_score_gemma":0.0019046284,"teacher_disagreement_score":0.0022285401,"about_ca_system_score_codex":0.00054902735,"about_ca_system_score_gemma":0.001004815,"threshold_uncertainty_score":0.00745517},"labels":[],"label_agreement":null},{"id":"W3120637385","doi":"10.2147/ott.s276912","title":"Case Report: Myeloid Sarcoma Development During Treatment for B Cell Lymphoblastic Lymphoma in a Boy with KRAS/NRAS Gene Mutations","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Neuroblastoma RAS viral oncogene homolog; KRAS; Myeloid sarcoma; Medicine; Lymphoma; Lymphoblastic lymphoma; Hematopoietic stem cell transplantation; Myeloid; Chemotherapy; Oncology; Cancer; Pathology; Internal medicine; Disease; Immunology; T cell","score_opus":0.02390182928471024,"score_gpt":0.2837764498929889,"score_spread":0.25987462060827865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120637385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97941726,0.0050479146,0.0045637935,0.0033958456,0.00030268572,0.00020298948,0.0004165765,0.00019571077,0.0064573446],"genre_scores_gemma":[0.99332714,0.0018209389,0.0020948136,0.0006861575,0.00044209775,0.000033167547,0.00013926861,0.00003537991,0.0014211197],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99944776,0.00007495232,0.00005223092,0.00017466235,0.00007427589,0.0001762612],"domain_scores_gemma":[0.9986216,0.0002837784,0.0003932024,0.00008412957,0.000076764365,0.00054056157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027423262,0.0013345585,0.0011303864,0.0015688086,0.0027225513,0.0012976087,0.00079071807,0.003999416,0.0023302753],"category_scores_gemma":[0.0017278534,0.0009780816,0.0010378403,0.0011611107,0.0012405625,0.001682,0.0012966205,0.0032787325,0.0009317137],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034575172,0.000031655272,0.0069864425,0.00002542525,0.000006233287,0.9907953,0.00022578936,0.000056876288,0.00057072163,0.00013674812,0.00020206862,0.000928109],"study_design_scores_gemma":[0.0000064158335,0.00003923037,0.0027263847,0.00000944031,0.0000078653875,0.9962132,0.00010258913,0.00008624852,0.00033491844,0.00006914597,0.0003989232,0.000005651099],"about_ca_topic_score_codex":0.0018750973,"about_ca_topic_score_gemma":0.0022739323,"teacher_disagreement_score":0.003999416,"about_ca_system_score_codex":0.0009151201,"about_ca_system_score_gemma":0.00065472315,"threshold_uncertainty_score":0.0077955127},"labels":[],"label_agreement":null},{"id":"W3120829320","doi":"10.2147/ott.s242248","title":"Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets","year":2021,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"European Association of Urology","keywords":"Medicine; Bladder cancer; Metastasis; Pathological; Angiogenesis; Cancer; Oncology; Disease; Tumor progression; Urokinase receptor; Plasminogen activator; Internal medicine; Cancer research","score_opus":0.06068501049646511,"score_gpt":0.37684074340441415,"score_spread":0.316155732907949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120829320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009604007,0.9862634,0.0005015698,0.0024101508,0.00013413152,0.000024282883,0.00030751512,0.000011722865,0.0007432124],"genre_scores_gemma":[0.11542612,0.87838733,0.0023702038,0.0014026343,0.000903553,0.00010929348,0.0007649204,0.000005349174,0.00063056935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995716,0.00016247499,0.00009099413,0.000051522667,0.00008422888,0.00003909323],"domain_scores_gemma":[0.99731463,0.0014227304,0.000686054,0.000055387918,0.00044183971,0.00007929732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019098195,0.00038204744,0.0013501567,0.0019849713,0.00016825761,0.0011854068,0.0004498308,0.0008174291,0.0027115766],"category_scores_gemma":[0.0027154698,0.00016102707,0.0011598134,0.0032190199,0.00027014903,0.0016835652,0.00033261412,0.00074443105,0.00040260667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014532144,0.00040421408,0.039105047,0.1467532,0.0018142546,0.0023542694,0.0004682472,0.0013673068,0.018510222,0.0033973635,0.013215898,0.7711568],"study_design_scores_gemma":[0.00079433643,0.0043466915,0.3229878,0.093238585,0.016756522,0.016507866,0.0035027682,0.006247532,0.014558329,0.02149366,0.49924833,0.0003176108],"about_ca_topic_score_codex":0.0012800163,"about_ca_topic_score_gemma":0.0020239113,"teacher_disagreement_score":0.0027115766,"about_ca_system_score_codex":0.0007488214,"about_ca_system_score_gemma":0.0024824454,"threshold_uncertainty_score":0.0101002455},"labels":[],"label_agreement":null},{"id":"W3127330586","doi":"10.2147/ott.s291086","title":"Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"Government of Jiangsu Province; Natural Science Foundation of Jiangsu Province; National Natural Science Foundation of China","keywords":"In vivo; Cancer research; Immune system; Tumor microenvironment; T cell; Immunotherapy; In vitro; Cytotoxic T cell; CD3; Antibody; Chemistry; Antigen; CD8; Medicine; Immunology; Biology; Biochemistry","score_opus":0.019489528036816608,"score_gpt":0.28453166111524125,"score_spread":0.26504213307842467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127330586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288166,0.0027938592,0.0021012365,0.00008715154,0.000051145336,0.00006551496,0.00017499187,0.00018533235,0.0016592027],"genre_scores_gemma":[0.9965766,0.0007838418,0.0016284776,0.00005210308,0.000022800496,0.000051118757,0.00022211373,0.000014924068,0.0006480114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985504,0.00002168897,0.000014978133,0.000033324697,0.000031870844,0.000043121578],"domain_scores_gemma":[0.99991333,0.000012069418,0.0000241746,0.000011867532,0.000009399178,0.00002911362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014899211,0.0004599559,0.00043436355,0.00025105296,0.00008195479,0.00023784202,0.00019923801,0.00020518739,0.0008093459],"category_scores_gemma":[0.00010591264,0.000070036265,0.00026159853,0.0002437373,0.00018813186,0.0001282067,0.00015536588,0.0006094629,0.00024072707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090525835,0.000340784,0.0005976666,0.00014912218,0.000028597073,0.000109417815,0.000032596312,0.0004784085,0.9825172,0.00008358968,0.0003178183,0.014439531],"study_design_scores_gemma":[0.000141133,0.0036762152,0.003063162,0.00001443268,0.0000843021,0.00046034888,0.000014052413,0.0017276516,0.9873169,0.000040516108,0.003454888,0.000006371596],"about_ca_topic_score_codex":0.0004315301,"about_ca_topic_score_gemma":0.00066132133,"teacher_disagreement_score":0.0008093459,"about_ca_system_score_codex":0.00028282625,"about_ca_system_score_gemma":0.0002656319,"threshold_uncertainty_score":0.002707541},"labels":[],"label_agreement":null},{"id":"W3159335234","doi":"10.2147/ott.s291801","title":"A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; Merck Sharp and Dohme; EMD Serono; Genentech; Plexxikon; Bausch Health; STCube; PharmaMar; European Society for Medical Oncology; Astellas Pharma; Silverback Therapeutics; Daiichi Sankyo Europe; National Cancer Institute; Calithera Biosciences; Aminex Therapeutics; Agios Pharmaceuticals; IFM Therapeutics; Symphogen; Pfizer; Incyte; Boston Pharmaceuticals; Five Prime Therapeutics; Loxo Oncology; Astex Pharmaceuticals; Eli Lilly and Company; National Comprehensive Cancer Network; Principia Biopharma; University of Texas MD Anderson Cancer Center; Puma Biotechnology; National Institutes of Health; BioMarin Pharmaceutical; Regeneron Pharmaceuticals; Baxalta; Immune Deficiency Foundation; Helsinn; Exelixis; Karyopharm Therapeutics; Bristol-Myers Squibb; American Society of Clinical Oncology; Sanofi; Amgen","keywords":"Crizotinib; Pazopanib; Medicine; ROS1; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Progressive disease; Gastroenterology; Pharmacology; Cancer; Sunitinib; Chemotherapy; Lung cancer; Adenocarcinoma","score_opus":0.00900558308648964,"score_gpt":0.2918006701008566,"score_spread":0.28279508701436695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159335234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919614,0.0027984676,0.00036640264,0.0005523942,0.0001354501,0.0014050438,0.00064754236,0.0000806551,0.002052557],"genre_scores_gemma":[0.9933082,0.0014781993,0.0010351498,0.0004677336,0.00017817058,0.00091136945,0.0014545036,0.000017305574,0.0011494039],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995989,0.00015606864,0.000026123407,0.00008828733,0.000044192504,0.00008639725],"domain_scores_gemma":[0.9993399,0.000079382,0.00011447623,0.000039608472,0.000035443165,0.00039107224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012235035,0.0016008965,0.0022707377,0.0004161262,0.00042881197,0.0010167495,0.00073087,0.00092642184,0.003029672],"category_scores_gemma":[0.00092876935,0.0006024899,0.0010955376,0.0005545425,0.00089214963,0.00084301335,0.00045587964,0.003328679,0.000820909],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7665145,0.043745276,0.010273631,0.0014760952,0.002211856,0.0008896933,0.00042259993,0.0031556932,0.052777253,0.00032911738,0.006401054,0.11180319],"study_design_scores_gemma":[0.6423307,0.3357125,0.0140863005,0.000042156415,0.000563337,0.0007012902,0.000054153505,0.0014747947,0.0026483203,0.00014472217,0.0022172697,0.000024520514],"about_ca_topic_score_codex":0.0012603435,"about_ca_topic_score_gemma":0.0030373961,"teacher_disagreement_score":0.003029672,"about_ca_system_score_codex":0.0012590525,"about_ca_system_score_gemma":0.0015915813,"threshold_uncertainty_score":0.010135293},"labels":[],"label_agreement":null},{"id":"W3190167812","doi":"10.2147/ott.s297336","title":"Long Non-Coding RNA TRG-AS1 Promoted Proliferation and Invasion of Lung Cancer Cells Through the miR-224-5p/SMAD4 Axis","year":2021,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Gene knockdown; Downregulation and upregulation; Cell growth; Cancer research; Lung cancer; Western blot; Long non-coding RNA; Competing endogenous RNA; Biology; microRNA; RNA; Cell culture; Gentamicin protection assay; Molecular biology; Medicine; Pathology; Gene; Biochemistry","score_opus":0.013700575000453364,"score_gpt":0.2897370582226619,"score_spread":0.27603648322220853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190167812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684219,0.016690377,0.007603853,0.00072651857,0.00030283662,0.00009127827,0.0012068051,0.00047978104,0.004476696],"genre_scores_gemma":[0.98706347,0.0046126177,0.0032250003,0.0002711582,0.00004825035,0.000075739685,0.0009557566,0.000036946803,0.0037111263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977154,0.000029997858,0.00001831104,0.00005015472,0.00008268807,0.00004727267],"domain_scores_gemma":[0.9999076,0.000011978748,0.00003169725,0.000008029613,0.000021482725,0.000019222056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022088441,0.00047607772,0.00034812553,0.00033691505,0.00025522144,0.000445388,0.0002144068,0.00027004885,0.0018503042],"category_scores_gemma":[0.00014004837,0.00016952468,0.0006512484,0.00020449424,0.0003189152,0.0002621431,0.00025747585,0.0007502968,0.000512949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035185175,0.000054597123,0.0014542609,0.0003497805,0.0000337388,0.00021702734,0.00004442441,0.00022760934,0.991458,0.0002747614,0.00030061344,0.0052333376],"study_design_scores_gemma":[0.000066041684,0.0009235982,0.018945303,0.00004267597,0.00017267243,0.0008428265,0.00018218094,0.0031757804,0.96216196,0.00024162781,0.013215728,0.000029683864],"about_ca_topic_score_codex":0.0005230675,"about_ca_topic_score_gemma":0.00096576556,"teacher_disagreement_score":0.0018503042,"about_ca_system_score_codex":0.00038360397,"about_ca_system_score_gemma":0.0004727093,"threshold_uncertainty_score":0.0061898828},"labels":[],"label_agreement":null},{"id":"W4226296095","doi":"10.2147/ott.s346725","title":"Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib","year":2022,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Afatinib; PTEN; Cancer research; Medicine; Epidermal growth factor receptor; Temozolomide; Cancer; Gefitinib; Oncology; Mutation; Internal medicine; Glioma; Biology; Gene; PI3K/AKT/mTOR pathway; Signal transduction; Genetics","score_opus":0.007874613956298807,"score_gpt":0.24204197147624149,"score_spread":0.23416735751994266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226296095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859005,0.0002806419,0.00019267754,0.00005568266,0.000006553882,0.000013439845,0.0004618853,0.000012610682,0.00038641144],"genre_scores_gemma":[0.9986161,0.000093915114,0.0001342537,0.00003487139,0.000005291511,0.000009891824,0.0009244059,0.0000045436714,0.00017672814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999813,0.000016559039,0.000022968801,0.00005422359,0.00004710461,0.000046114863],"domain_scores_gemma":[0.9997261,0.00004721326,0.00006282289,0.000027302016,0.000068679365,0.00006789276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105232,0.00020085588,0.0002788954,0.00059828034,0.0003897922,0.00032690604,0.00018762113,0.00037068297,0.0008034035],"category_scores_gemma":[0.00056000095,0.00010986986,0.00021019691,0.0005458783,0.00017475632,0.00014776419,0.00023875834,0.00028640972,0.00024164624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017043237,0.00020117906,0.8447261,0.000092252594,0.00016102816,0.029776428,0.0007536697,0.00041999054,0.09195293,0.00010077624,0.0010718346,0.029039552],"study_design_scores_gemma":[0.000026620872,0.0006887169,0.9458122,0.000007219605,0.00008698425,0.041001145,0.00035648135,0.00052506744,0.0089664245,0.00006856364,0.002446513,0.000013952963],"about_ca_topic_score_codex":0.0024932437,"about_ca_topic_score_gemma":0.0022760872,"teacher_disagreement_score":0.0024932437,"about_ca_system_score_codex":0.00030219392,"about_ca_system_score_gemma":0.00018758015,"threshold_uncertainty_score":0.004957497},"labels":[],"label_agreement":null},{"id":"W4307636191","doi":"10.2147/ott.s370244","title":"Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge","year":2022,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Diabetic ketoacidosis; Ketoacidosis; Type 2 diabetes; Type 1 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.03314721665539851,"score_gpt":0.24566408464348818,"score_spread":0.21251686798808966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307636191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675028,0.0080666095,0.0018415449,0.0114858225,0.00041787323,0.00015131709,0.0001631841,0.00008162976,0.01028915],"genre_scores_gemma":[0.99211836,0.002636367,0.0007784878,0.0026116818,0.0005482601,0.00001777686,0.000088520304,0.000013394362,0.0011871008],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99969995,0.00003935754,0.000041691175,0.000061257226,0.00005232093,0.00010546947],"domain_scores_gemma":[0.99897265,0.00021099857,0.00027733095,0.000041692878,0.00008710426,0.00041023403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025793927,0.00065350067,0.00068180857,0.0009558585,0.0016084893,0.000988376,0.00057918375,0.0026211753,0.001227833],"category_scores_gemma":[0.0022794248,0.00044012244,0.0008404472,0.00076234585,0.000746625,0.0015538506,0.0006085374,0.004275589,0.0004282811],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023338074,0.00017646617,0.04502342,0.00004439328,0.000016441658,0.94921064,0.0005375059,0.00012282057,0.0005192583,0.0001684676,0.0006662629,0.0032810862],"study_design_scores_gemma":[0.00002977086,0.00043755138,0.024596341,0.000053719767,0.000033239234,0.971161,0.00061003404,0.00048262384,0.00046003127,0.0003527209,0.0017472978,0.000035661924],"about_ca_topic_score_codex":0.0028832078,"about_ca_topic_score_gemma":0.0025642896,"teacher_disagreement_score":0.0028832078,"about_ca_system_score_codex":0.0013266931,"about_ca_system_score_gemma":0.00071291707,"threshold_uncertainty_score":0.009625912},"labels":[],"label_agreement":null},{"id":"W4309614828","doi":"10.2147/ott.s366625","title":"CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights","year":2022,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Memorial University of Newfoundland","funders":"","keywords":"CD24; Cancer research; Lymphoma; Biomarker; Leukemia; Medicine; Immunology; Immune system; Biology; Cancer; Internal medicine; Cancer stem cell","score_opus":0.013971225102938576,"score_gpt":0.24779340506140374,"score_spread":0.23382217995846516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309614828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011094992,0.9985757,0.00009091725,0.00036360903,0.00013946036,0.0000027491758,0.000012788142,0.0000064719256,0.0006973318],"genre_scores_gemma":[0.0010431615,0.9976585,0.0001536176,0.0003733917,0.0002408323,0.000007023544,0.00003390285,0.0000017682338,0.0004878892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985886,0.000028145803,0.000020308771,0.00002804281,0.0000492539,0.000015469663],"domain_scores_gemma":[0.9997913,0.00011172809,0.00002501431,0.00000470413,0.00004785339,0.000019313731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042613578,0.0005321377,0.0009805963,0.0011500464,0.0001667235,0.00074377056,0.00051062624,0.0008537344,0.0023394858],"category_scores_gemma":[0.0005846585,0.00016240854,0.0004226841,0.00095518434,0.00029367898,0.00084904506,0.0004310304,0.0018166034,0.0012722834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007139025,0.00004076832,0.00020990125,0.005824491,0.000060736387,0.0001324673,0.000033217504,0.00020934749,0.0010806662,0.0021635739,0.02561905,0.96455425],"study_design_scores_gemma":[0.000021883558,0.00011758625,0.00073201343,0.002161098,0.00011204387,0.0015922055,0.000038663944,0.00010343279,0.0004647488,0.0014576614,0.9931851,0.000013388625],"about_ca_topic_score_codex":0.00050280907,"about_ca_topic_score_gemma":0.0010586825,"teacher_disagreement_score":0.0023394858,"about_ca_system_score_codex":0.00042916345,"about_ca_system_score_gemma":0.000525768,"threshold_uncertainty_score":0.007826328},"labels":[],"label_agreement":null},{"id":"W4393090889","doi":"10.2147/ott.s442504","title":"Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin","year":2024,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Natural Science Foundation of China","keywords":"Paxillin; Cell biology; Cancer research; Melanoma; Expression (computer science); Focal adhesion; Chemistry; Biology; Computer science; Phosphorylation","score_opus":0.0049351374831575244,"score_gpt":0.21349894587682838,"score_spread":0.20856380839367086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883385,0.0056575807,0.0022325914,0.00018453515,0.000057668723,0.00004192669,0.00035223065,0.00012324374,0.0030117875],"genre_scores_gemma":[0.9909949,0.0028700538,0.0017505572,0.000076638775,0.00001492295,0.00006160542,0.00048176124,0.000011759731,0.0037379137],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991345,0.000016884,0.000009432935,0.000016328444,0.000026131978,0.000017773937],"domain_scores_gemma":[0.9999571,0.0000080815225,0.000014616312,0.0000052100363,0.0000049949326,0.000009958584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009660841,0.00027238927,0.00016841106,0.00026318638,0.00011979729,0.00014973913,0.00013172934,0.00017541794,0.001766738],"category_scores_gemma":[0.000087067274,0.000082770595,0.00028607622,0.000114522685,0.00013444925,0.00011779063,0.0001351048,0.00040480978,0.0002955229],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012877707,0.000038528993,0.00022372733,0.000078463214,0.000007215714,0.00004421354,0.000008998567,0.000044376466,0.9968952,0.00004452573,0.00006775954,0.0024180855],"study_design_scores_gemma":[0.000037571397,0.00092150946,0.008441554,0.000015337566,0.00003214602,0.00031800414,0.0000370748,0.00079312176,0.9842775,0.000044934022,0.005076737,0.0000045606366],"about_ca_topic_score_codex":0.0003203792,"about_ca_topic_score_gemma":0.0006029981,"teacher_disagreement_score":0.001766738,"about_ca_system_score_codex":0.000111945505,"about_ca_system_score_gemma":0.000148069,"threshold_uncertainty_score":0.005910337},"labels":[],"label_agreement":null},{"id":"W4393120052","doi":"10.2147/ott.s444536","title":"Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study","year":2024,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Receiver operating characteristic; Cohort; Retrospective cohort study; Hepatocellular carcinoma; Internal medicine; Concordance; Cirrhosis; Framingham Risk Score","score_opus":0.021777842447134134,"score_gpt":0.23255064357896907,"score_spread":0.21077280113183494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393120052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361885,0.00018302513,0.0055568973,0.00004207326,0.000013121777,0.00003391561,0.0001982313,0.000023387682,0.0003304402],"genre_scores_gemma":[0.9972619,0.00008560657,0.0021473863,0.000012719573,0.000008027736,0.000025542233,0.00034941806,0.000004779521,0.000104585306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989986,0.000484412,0.00011898785,0.00015467036,0.0001907623,0.000052571417],"domain_scores_gemma":[0.9971507,0.001453404,0.0004221561,0.0003569486,0.0005005343,0.0001162431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004123579,0.0005255841,0.0004305696,0.0011376927,0.0003115563,0.00074767234,0.00053000107,0.00048984546,0.00064268213],"category_scores_gemma":[0.006843142,0.00027689585,0.0005326635,0.0005124564,0.00023507439,0.0005875172,0.00044881675,0.0004434097,0.00027247812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022977422,0.00010751528,0.9863863,0.000017661585,0.00011958561,0.0002242767,0.000060909366,0.003091946,0.00051645393,0.000035888992,0.00010535131,0.009104385],"study_design_scores_gemma":[0.000064958236,0.0015226919,0.7292359,0.00008752197,0.00040733186,0.0029423228,0.00040387726,0.26153874,0.002205016,0.000290817,0.0012643922,0.000036412563],"about_ca_topic_score_codex":0.0015182854,"about_ca_topic_score_gemma":0.0014221105,"teacher_disagreement_score":0.004123579,"about_ca_system_score_codex":0.0004241699,"about_ca_system_score_gemma":0.0005177561,"threshold_uncertainty_score":0.02180785},"labels":[],"label_agreement":null},{"id":"W4406802705","doi":"10.2147/ott.s496228","title":"Dynamic Coupling of MAPK Signaling to the Guanine Nucleotide Exchange Factor GEF-H1","year":2025,"lang":"en","type":"review","venue":"OncoTargets and Therapy","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto","keywords":"Guanine nucleotide exchange factor; Guanine; MAPK/ERK pathway; Cell biology; Coupling (piping); Nucleotide; Factor (programming language); Chemistry; Signal transduction; Computational biology; Bioinformatics; Biology; Medicine; Computer science; Biochemistry; Materials science; Gene","score_opus":0.02186933261750735,"score_gpt":0.30884432124341465,"score_spread":0.2869749886259073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406802705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1513421,0.8169567,0.0075704064,0.001517649,0.0012311148,0.00005839165,0.0006224628,0.00035902785,0.020342138],"genre_scores_gemma":[0.5276274,0.45492586,0.0030279965,0.0005524016,0.00065525435,0.00006990199,0.0007814849,0.000040084182,0.012319576],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999391,0.000009262942,0.0000058345913,0.000015439125,0.000019474826,0.000010917233],"domain_scores_gemma":[0.9999746,0.0000052136365,0.0000066194784,0.0000012840868,0.000008142246,0.000004122761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010453141,0.00030634122,0.00024144562,0.00018778346,0.00011752058,0.0003289328,0.00020955257,0.00025681686,0.001168901],"category_scores_gemma":[0.00008158807,0.00006598869,0.00015755805,0.00014723635,0.000105960724,0.00026838688,0.00016139199,0.0003735299,0.00052592583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036690064,0.0000510466,0.00081313646,0.006164744,0.000115131785,0.00092858146,0.00011728426,0.0011078204,0.8023197,0.004578281,0.0063090203,0.17712827],"study_design_scores_gemma":[0.00006474849,0.00057227345,0.006680179,0.0002957912,0.00018715771,0.00301021,0.00014762688,0.0013877477,0.50744575,0.0019254148,0.47823313,0.00004998682],"about_ca_topic_score_codex":0.00020357559,"about_ca_topic_score_gemma":0.00033195107,"teacher_disagreement_score":0.001168901,"about_ca_system_score_codex":0.00032897765,"about_ca_system_score_gemma":0.00021356884,"threshold_uncertainty_score":0.0039103627},"labels":[],"label_agreement":null},{"id":"W4414003234","doi":"10.2147/ott.s398118","title":"The Role of CELMoD Agents in Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Janssen Pharmaceuticals; Kite Pharma; Genentech; Servier; Regeneron Pharmaceuticals; Adaptive Biotechnologies; Karyopharm Therapeutics; BeiGene; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; TG Therapeutics; Amgen; Pfizer","keywords":"Multiple myeloma; Medicine; Computer science; Computational biology; Internal medicine; Biology","score_opus":0.0251265564514516,"score_gpt":0.32038975439380807,"score_spread":0.29526319794235645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414003234","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013052155,0.95877707,0.0018031644,0.007460385,0.0009704609,0.000051154664,0.00010049351,0.000096084186,0.01768897],"genre_scores_gemma":[0.12338869,0.8546337,0.005160203,0.007193895,0.0026407707,0.00010283004,0.00027242274,0.00003115362,0.0065764273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977833,0.00006133505,0.000018787478,0.000033935965,0.00006714049,0.000040489216],"domain_scores_gemma":[0.9996871,0.00009483258,0.000078394216,0.000016849104,0.000058939415,0.000063858104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010467501,0.00046858974,0.0004886206,0.0005849476,0.00025907104,0.00093976123,0.00054286164,0.00097076,0.003163942],"category_scores_gemma":[0.00064561353,0.00012548089,0.00041153296,0.00046627547,0.0007323617,0.0008383664,0.000615276,0.001580261,0.0011132037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011042061,0.0005061724,0.001842008,0.0019869925,0.00008778569,0.00087998464,0.00007607107,0.0012550028,0.019734995,0.014072539,0.012642153,0.9458121],"study_design_scores_gemma":[0.00061079924,0.0041353586,0.0054461258,0.00134903,0.00015054533,0.0038234836,0.00007834098,0.0013789603,0.01577733,0.010623847,0.956576,0.000050320967],"about_ca_topic_score_codex":0.0006403112,"about_ca_topic_score_gemma":0.00092387537,"teacher_disagreement_score":0.003163942,"about_ca_system_score_codex":0.0009373226,"about_ca_system_score_gemma":0.00084669515,"threshold_uncertainty_score":0.010584414},"labels":[],"label_agreement":null},{"id":"W4415506104","doi":"10.2147/ott.s537253","title":"Evaluating the Prognostic Value of a Pan-Cancer Circulating Tumor DNA Next-Generation Sequencing Panel in Advanced Cancer Patients","year":2025,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexen (Canada)","funders":"Incheon St. Mary's Hospital, Catholic University of Korea","keywords":"Circulating tumor DNA; Circulating tumor cell; Liquid biopsy; Disease; Value (mathematics); DNA sequencing; Biomarker; Predictive value","score_opus":0.06350176517418692,"score_gpt":0.33498611451710997,"score_spread":0.27148434934292304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415506104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838626,0.0007441584,0.00040428157,0.000057939968,0.00000965504,0.000009247278,0.00017181541,0.000008600435,0.00020811844],"genre_scores_gemma":[0.99906474,0.00011444079,0.00040281157,0.00004136699,0.000012446294,0.000007303665,0.00027358122,0.0000014487683,0.000081852915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996648,0.00011854126,0.000030134288,0.0000835396,0.00006499974,0.0000380328],"domain_scores_gemma":[0.999014,0.00037422666,0.00029672324,0.00005029157,0.0001184825,0.00014611785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070704846,0.00027517127,0.00040623816,0.0003544362,0.00017055601,0.0004222367,0.00018426764,0.00037744103,0.0006968019],"category_scores_gemma":[0.0017923248,0.00011005535,0.00018623305,0.00035173693,0.00014766263,0.0003253031,0.0002428329,0.00032064994,0.0001606835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011785931,0.00005194625,0.97759193,0.000028665565,0.000066877124,0.0001049216,0.000039731418,0.00066092337,0.0042735036,0.000022887836,0.00015762198,0.015822329],"study_design_scores_gemma":[0.000087074666,0.0019403665,0.9794907,0.00003368071,0.0002045799,0.0012087523,0.00012105709,0.010432754,0.004888614,0.00013671439,0.0014389844,0.0000167191],"about_ca_topic_score_codex":0.00053564826,"about_ca_topic_score_gemma":0.0009025008,"teacher_disagreement_score":0.00070704846,"about_ca_system_score_codex":0.00023683072,"about_ca_system_score_gemma":0.00022132584,"threshold_uncertainty_score":0.0037392378},"labels":[],"label_agreement":null}]}